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As an emerging technology, photoacoustic (PA) imaging (PAI) has gained lots of 
progresses in the past two decades. By combing optical contrast with ultrasound detection, 
PAI can maintain high spatial resolution in deeper regions. Furthermore, with the aid of 
multispectral imaging, PAI can reveal functional information such as oxygenation saturation 
(SO2), which is closely related to tumor malignancy. With the above advantages, nowadays 
PAI has gained lots of progresses in clinically translatable research. These research shows that 
PAI has the potential to complement existing imaging techniques such as ultrasound (US) 
imaging for cancer detection, disease evaluation and prognosis monitoring. 
This thesis mainly discusses the clinical application of PAI, including system design and 
clinical research. Particularly, it presents several studies including the development of PA/US 
imaging system and the clinical evaluation of PA/US imaging in diagnosis of superficial cancer. 
The main research results and the major novelties of this thesis include: 
1) The collaborative development of the PA/US imaging system for clinical studies, 
where the author was mainly responsible for the design of optical path and the trigger 
method between the laser and the US system. 
2) The design of optical fluence compensation strategy based on clinical US structural 




and then utilizes the known optical absorption and scattering parameters to simulate 
optical fluence map in the imaging region. The simulated optical fluence map can 
then be used for correction of original PA images. The effectiveness of this strategy 
has been verified based on clinical PAI data. The proposed method can improve the 
accuracy of quantification PAI and restore PA signals in deeper regions.  
3) The collaborative study of PA/US imaging on thyroid nodules with the self-
developed 2D PA/US handheld imaging system. By comparing PAI results with 
color Doppler flow imaging (CDFI) results from 10 thyroid nodules, we found that 
PAI can reveal more abundant vessels than CDFI, and can thus provide valuable 
information in diagnosis of thyroid cancer.  
4) The design of the method for quantification analysis of 3D PA/US imaging on breast 
cancer. Specifically, this method first calculates the ellipse enclosing the tumor 
region with the minimum volume and then automatically segments the tumor regions 
and tumor surrounding regions. Next, the volumetric mean SO2 of tumor regions and 
tumor surrounding regions were calculated for quantification analysis. Our results 
demonstrate that quantification analysis of 3D functional PA/US imaging on breast 
cancers has the potential to improve the specificity in diagnosis of breast cancer.  




first reviewed. Next, in Chapter 2, the development of a clinical PA/US imaging system based 
on handheld US imaging is presented. The imaging ability of the newly developed system was 
verified with the phantom study as well as the in vivo study. After then, in Chapter 3, the 
optical fluence compensation method for handheld PA/US imaging based on tissue structural 
information provided in US imaging is introduced. The clinical result demonstrates that 
important tissue structures such as vessels in deeper tissue can be restored after fluence 
compensation based on the proposed method. Chapter 4 and Chapter 5 introduce the clinical 
studies based on the self-developed PA/US imaging systems, including 2D PA/US imaging of 
thyroid nodules, 3D PA/US imaging of breast cancer, and quantification analysis of the 
imaging results. The quantification analysis demonstrates that 3D functional PA/US imaging 
has the potential to improve the diagnosis specificity of breast cancer. 
In Chapter 6, the author presented the research conducted in Georgia Institute of 
Technology. In this chapter, the laser induced surface acoustic waves (SAWs) and acoustic 
radiation force (ARF) induced SAWs were compared. The results demonstrate that laser-
induced SAW imaging is able to perform stiffness evaluation and has the potential to provide 
higher spatial resolution.  
In Chapter 7, the author summarized the major novelties in this thesis and discussed 




CHAPTER 1  CLINICAL TRANSLATIONAL STUDIES OF 
PHOTOACOUSTIC IMAGING  
Since late 1990s, the photoacoustic (PA) imaging (PAI) has evolved into a clinically 
translatable imaging platform. PAI can not only provide both functional and molecular 
information, but also allow noninvasive soft-tissue characterization. PAI is being translated 
into the clinic with various clinical studies underway, including imaging of breast, joints, 
prostate, and ovarian, and it has the potential to complement existing imaging techniques such 
as ultrasound (US) for detecting cancer, characterization of diseases, prognosis and treatment 
monitoring. In this chapter, the mechanism of PAI is introduced. Then, several PAI systems as 
well as typical clinical applications are reviewed and discussed. 
1.1  The mechanism of PAI 
Photoacoustic effect was first introduced by Alexander Graham Bell in late 1800s[1]. 
However, it was until 1990s that PAI gains much progress owing to the development in laser, 
ultrasound detection and computer technologies. Studies have been carried out exploring this 
mechanism for clinical purposes since then[2-4]. Typically, nanosecond pulsed laser light is used 
to irradiate biological tissues, in which some tissue constituents absorb light and cause thermal 
expansion. The thermal expansion will then generate ultrasound waves (also called PA waves) 




PA image can be reconstructed based on appropriate algorithms[2,5,6]. Because the PA wave is 
ultrasound that has a much lower scattering coefficient in the soft tissue, PAI allows deeper 
tissue imaging while at the same time provides optical contrast which is closely related to 
inherent molecular information.  
1.1.1  Generation of PA signals 




= −𝜅𝑝 + 𝛽𝑇 (1.1) 
In this equation, 𝜅  represents for the isothermal compressibility; 𝛽  represents for the 
thermal coefficient of volume expansion; 𝑝 and 𝑇 represent for small changes in pressure 
(Pa) and temperature (K), respectively. For the typical short laser pulse, the following two 
conditions are generally met: 1) the thermal confinement; 2) the stress confinement. Equation 
(1.2) describes the thermal confinement, where 𝜏  is the laser pulse width, 𝑑𝑐  is the 
characteristic dimension of the heated region, and 𝛼𝑡ℎ is the thermal diffusivity (m
2/s). The 
stress confinement is described in Eq. (1.3), where 𝑣𝑠 is the speed of sound. 













volume expansion is negligible (𝑑𝑉 ≈ 0 in Eq. (1.1)) and the local pressure change 𝑝0 after 





For soft tissue, 𝜅  is about 5 × 10−10𝑃𝑎−1 , and 𝛽  is about 4 × 10−4𝐾−1 . 𝑝0  is thus 





where 𝐴𝑒  is the specific optical absorption (J/m
3), 𝐶𝑉  is the specific heat capacity at 
constant volume, and 𝜂𝑡ℎ is the percentage of the absorbed energy converted to heat. Given 





 𝑝𝑜 = Γ𝜂𝑡ℎ𝐴𝑒  (1.7) 
Given 𝐴𝑒 = 𝐹 × 𝜇𝑎, where 𝐹 is the optical fluence (J/m
2), and 𝜇𝑎 is the optical absorption 
coefficient, Eq. (1.7) becomes Eq. (1.8): 
 𝑝𝑜 = Γ𝜂𝑡ℎ𝜇𝑎𝐹 (1.8) 
1.1.2  PA wave equation 
















  (1.9) 
The right-hand side of this equation represents the source term and the left-hand side of this 
equation describes the wave propagation. 𝑝(𝒓, 𝑡) is the acoustic pressure at location 𝒓 and 
time 𝑡. 𝐶𝑝 is the specific heat capacity at constant pressure. 𝐻(𝒓, 𝑡) is the heating function 
defined as the thermal energy converted per unit volume and per unit time. As shown in Eq. 
(1.10), 𝐻 is related to the 𝜂𝑡ℎ, the optical absorption coefficient 𝜇𝑎, and the optical fluence 
rate Φ. 
 𝐻 = 𝜂𝑡ℎ𝜇𝑎𝜙 (1.10) 
It’s worth noticing that the PA source term in Eq. (1.9) is the time derivative of 𝐻(𝒓, 𝑡) , 
indicating that only time-variant heating can produce a US pressure wave. 
The wave equation can be solved by using a Green function approach[2]. The Green 








) 𝐺(𝒓, 𝑡; 𝒓′, 𝑡′) = −𝛿(𝒓 − 𝒓′)𝛿(𝑡 − 𝑡′) (1.11) 




the solution of Eq. (1.11) is: 






 (1.12)  
With the above Green function, the PA wave equation can then be solved as Eq. (1.13) 












For a short pulse width which is within the acoustic stress confinement, the heating process 
can be treated approximately as Dirac delta function[7] as the following equation: 
 𝐻(𝒓′, 𝑡′) ≈ 𝑝0(𝑟′)/Γ × 𝛿(𝑡′) (1.14) 
Substituting the above equation into Eq. 1.13, 𝑝(𝒓) can be rewritten as Eq. (1.15): 













This expression denotes that the detected pressure at 𝒓 and time 𝑡 comes from sources over 





Fig1.1 The PA waves detected by a point detector at a certain time 𝑡 come from sources 
over a spherical shell centered at the detector position and a radius of 𝑣𝑠𝑡.
[7] 
1.1.3  Propagation of light and PA signals in tissue 
In tissue, light propagation is related to the scattering coefficient 𝜇𝑠 , the absorption 
coefficient 𝜇𝑎, the anisotropy factor g, as well as the light wavelength. It can be modeled by 
the radiative transfer equation (RTE)[2]. In general, RTE does not have an exact analytical 
solution but can be solved by numerical calculation, including Monte Carlo simulations and 
other modeling methods based on different ways of diffusion approximation[2]. For the 
strongly scattering medium, such as the living tissue, the reduced scattering coefficient 𝜇𝑠
′ =
(1 − 𝑔)𝜇𝑠 is a more appropriate parameter instead of the scattering coefficient. With planar 
illumination, the equation of the fluence rate in a uniform diffusive medium is as follows: 





where 𝜙0 is the illumination fluence, 𝑧 is the depth, and 𝜇𝑒𝑓𝑓 = √3𝜇𝑎(𝜇𝑎 + 𝜇𝑠′ ). Based on 
Eq. (1.16), the absorption of the tissue plays an important role in the transportation depth. 
According to the absorption spectra of tissue components such as water, blood and melanin[8], 
the near infrared (NIR) light generally penetrates much deeper than visible light. 
Different from light propagation, which suffers from strong scattering during propagation, 
PA waves (acoustic waves) have much lower scattering effects which are almost negligible in 
soft tissue. However, at high frequencies or in highly heterogeneous tissue such as the skull, 
the attenuation and wave distortion effect cannot be ignored. Besides, because the ultrasound 
attenuation coefficient increases with frequency, PAI systems detecting higher frequency 
ultrasound signals always have shallower detection depth. 
Due to the attenuation of both light and ultrasound, compensations are usually important 
especially for quantitative PAI. In addition, since PA signals have a broad bandwidth, it is also 
important to choose acoustic detectors with appropriate detection bandwidth. 
PAI is a scalable imaging modality, with the imaging depth varying from micrometers to 
centimeters. In general, the shallower the imaging depth is, the higher the spatial resolution 
can reach. For instance, the photoacoustic microscopy can image blood capillaries, but at the 
depth less than 1 mm. In this thesis, we focus on the PAI clinical applications for deep tissues, 




1.1.4  Clinical applications of PAI  
The optical absorption is closely related to the molecular structure of chromophores. 
Therefore, PAI has great potential for molecular imaging. The PA signal is directly correlated 
with the concentrations of the chromophores such as melanin, hemoglobin, fat, water, etc. 
Except for melanin in the skin, hemoglobin dominates the absorption in tissue due to its high 
optical absorption coefficient and concentration, and thus becomes the endogenous target of 
most PAI studies. In addition, the oxygenated hemoglobin (HbO2) and de-oxygenated 
hemoglobin (Hb) have a very different absorption behavior, so the oxygenation saturation (SO2) 
which represents for the concentration ratio of HbO2 to the total hemoglobin can be determined 
by using multiple PA illumination wavelengths. It is known that SO2 is very important for 
clinical diagnosis especially for cancer detection. For instance, a tumor with lower SO2 is 
considered more likely cancerous due to cancer’s hypoxic hallmark[9,10]. PAI has potential to 
provide this important physiological parameter to enhance the diagnostic accuracy in 
differentiating malignant tumors from benign ones[11]. In addition to the endogenous tissue 
contrast, PAI also has other advantages such as nonionizing, ease of integration into clinical 
US imaging systems, as well as affordability. By complementing existing imaging techniques 




1.2  Clinical PAI systems 
Clinical PAI systems are mainly composed of three elements: lasers, ultrasonic transducer 
(UST) array system, as well as data acquisition/processing systems. Because both the bulk 
absorption and scattering coefficients of tissue are low in the NIR region, light within this 
region can penetrate deeper into tissue[12]. Therefore, the NIR pulsed lasers with the 
wavelengths ranging from 650 to 1100 nm are commonly used. In addition, specific 
wavelengths can be chosen for imaging specific components such as endogenous photo-
absorbers including hemoglobin, water, fat and exogenous photo-absorbers such as methylene 
blue[13,14]. In practice, to have enough laser power with satisfied spatial resolution, lasers with 
short pulse width less than 100 nanoseconds are commonly employed. These lasers normally 
can output high pulse energy (several tens to hundreds of mJ/pulse at 700-1,100 nm) to achieve 
a high signal-to-noise ratio (SNR)[6]. However, the pulse repetition rates (PRFs) of these lasers 
are usually several tens of Hz, limiting the frame rate of PAI. Besides, high-powered lasers are 
expensive and bulky. Alternatively, small laser diodes and light emitting diodes (LEDs) also 
have the potential to be used as the excitation source for PAI of shallower regions (such as 
skin) because they have high PRFs of several kHz, which allow signals to be averaged by 
multiple times to improve the SNR[15,16]. In terms of UST arrays, the linear array is most 
commonly used in clinical PAI systems, including both straight and curved linear arrays[17]. 




processing and beamforming technologies[18]. Due to the inherent similarities, some existing 
commercially available US systems can be modified for laser integration, PA beamforming 
and PA display to become a clinical PAI system[19]. To acquire PA signals from multiple 
transducers, multi-channel parallel data acquisition systems need to be employed[13,20,21].  
In the following sections, the clinical PAI systems with three types of imaging array 
including straight linear arrays, curved linear arrays, and volumetric arrays are introduced. 
1.2.1  Clinical PAI systems based on straight linear arrays 
The combination of PAI with handheld linear arrays attracts lots of interest these years 
due to its ability to perform conventional US imaging and PAI simultaneously. Due to the light 
penetration limitation, handheld PA/US systems generally use the linear arrays with 
frequencies ranging from 5 MHz to 20 MHz, which are usually used in clinical ultrasound 
imaging for small and shallow structures including blood vessel, breast, and thyroid. In this 
section, PAI systems with straight linear arrays for multiple clinical applications including 
detecting breast cancer[11,14], fine needle aspiration biopsy of sentinel lymph nodes[14] and 
evaluating arthritis[15,22] are reviewed. In these systems, handheld US probes are usually 
combined with angled optical fiber bundles placed along two sides of US probe. The angles 
between fiber bundles and the transducers are adjusted so that the two light beams coming out 




the imaging targets and depths, the center frequency of the transducer in these platforms varies 
as well. 
The clinical study of PA/US imaging enrolling the most human subjects was carried out 
by Neuschler et al[11]. This clinical study aimed at exploring the diagnostic value of PA/US 
imaging on breast cancers. Over two thousand subjects with breast tumors were enrolled for 
PA/US imaging in multiple study centers. US imaging was carried out independently with 
PA/US imaging. Traditional Breast Imaging Reporting and Data System (BI-RADS) grading 
was performed first, followed by independent PA scores grading. The system used in this study 
(Seno Medical, San Antonio, TX, USA) can perform both stand-alone gray-scale US imaging 
and dual mode PA/US imaging. A 128-element transducer with a one-to-two fiber bundle 
placed along the probe was used for dual mode imaging, as shown in Fig1.2 (a). This system 
used two wavelengths: 757 nm and 1064 nm, provided by an Alexandrite laser and a 1064 nm 
Nd: YAG laser respectively. The functional information including relative concentration of 
total hemoglobin and SO2 calculated from PAI at these two wavelengths were color-coded and 
shown overlaid with US imaging. To compare the diagnostic efficiency with the stand-alone 
US imaging, five PA scores including vessel score, blush score, hemoglobin score, boundary 
zone score, peripheral zone score were graded independently by seven physicians (Fig1.2 (b)). 
The comparison between BI-RADS grading and PA scoring shows that PA/US exceeds US by 





Fig1.2 (a) Schematic diagram of the PA/US dual mode transducer; (b) Examples of 
minimum and maximum scores for each PA feature. The top row is an example of the lowest 
score in each category and the bottom row is an example of the highest score in each 
category.[11] 
Alejandro Garcia-Uribe et al. proposed a method using PA/US imaging to guide fine 
needle aspiration biopsy of a sentinel lymph node for staging of breast cancers[14]. In their 
study, a modified clinical US system (iU22, Philips Healthcare) and two straight linear arrays 
(L12-5 and L8-4, Philips Healthcare) were used for acquisition of PA/US signals (Fig1.3 (a)). 
A tunable laser (PrecisionScan-P, Sirah, Kaarst, Germany) pumped by an Nd: YAG laser 
(QuantaRay PRO-350-10, Spectra-Physics, Santa Clara, CA) was employed to provide 667 
nm laser pulse with a pulse duration of 6.5 ns at a repetition rate of 10 Hz. 1064 nm laser pulse 
was provided directly by an Nd: YAG laser. As seen in Fig1.3 (b)i-ii, at 650 nm wavelength, 
PA signals came from both methylene blue inside lymphatic vessels as well as other blood 
vessels, while at 1064 nm wavelength, PA signals only came from blood vessels. By taking 
the fractional change, the methylene blue was highlighted (Fig1.3 (b)iii), and as a result, the 






Fig1.3 (a) Schematic diagram of the dual-mode PA and US imaging system developed by 
Garcia-Uribe et al; (b) Photoacoustic image acquired at (i) 650nm, (ii) 1064 nm, (iii) the 
fractional change between 650 nm and 1064 nm.[14] 
Clinical PA/US imaging with straight linear arrays has also been studied for vessel 
visualization[23,24]. For example, Kaku Irisawa et al. performed a feasibility study on diabetic 
foot patients[23]. Their system employed a light weight Alexandrite laser and a commercial 
portable US system (FUJIFILM FCI, FUJIFILM Medical Co., Ltd) equipped with a probe of 
9 MHz (Fig1.4 (a)). It’s worth noticing that the white-colored acoustic lens was used on the 




signal amplitudes were found in the diabetic foot patient compared to the healthy volunteer 
(Fig1.4 (b)). In another experiment where a linear scanning stage was used to scan the 
transducer, they successfully visualized small vessels with low flow velocity in 3D PAI, which 
complemented the information provided by US Doppler imaging (Fig1.4 (c)). 
 
Fig1.4 (a) Photographs of the components of the PA/US system including (i) PA/US system 
(ii) PA/US dual mode probe (iii) linear stage scanner for 3D imaging; (b) Comparison of 
PA images of the foot dorsum from (i) a diabetic foot patient and (ii) a healthy volunteer; 
(c) 3D images of a finger acquired by scanning the transducer: (i) Maximum-intensity-
projection image of the fingertip. US Doppler and PA signals are shown in red and gray 
scale, respectively. (ii) Sliced image showing the bow-shaped artery in the fingertip. (iii) 
Maximum-intensity-projection PA image of the palm. (iv) Photograph and imaged area of 
the finger and the palm.[23] 
Another study aiming at measuring vascular compliance by PA/US imaging was carried 
out by Pengfei Hai et al.[24]. The commercial PAI system Vevo LAZR (Visualsonics Inc.) 
together with a 21 MHz straight linear array were used. PAI before and after applying an 
external compression force on human arm revealed the absolute Young’s modulus of the 




In addition to the above applications, straight linear arrays are also investigated for 
diagnosis of arthritis[15,22]. Early symptoms of inflammation including hyper-vascularity and 
hypoxia can be well identified with PA/US imaging. In a study reported by Pim J. van den 
Berg et al[15]. A commercial 128-element linear array (SL 3323, ESAOTE) with a center 
frequency of 7.5 MHz was integrated with a size-comparable diode laser module, as shown in 
Fig1.5 (a). A modified US system (MylabOne, ESAOTE) was employed for data acquisition 
and reconstruction. The 808 nm wavelength was chosen because it is the isosbestic point of 
oxygenated and deoxygenated hemoglobin and thus is independent of SO2. The patient’s hands 
were submerged in water for US coupling (Fig1.5 (b)). US Doppler and PA/US imaging were 
performed. Their results show that the inflamed joints have higher PA amplitudes than non-
flamed joints, and thus demonstrate that the system has the potential of detecting synovitis 





Fig1.5 (a) The PA/US probe (left) showing the light delivery window (dark aperture). The 
patient’s hand is submerged in water (right) where it rests on a series of supports. (b) PA/US 
and US/Power Doppler images of an inflamed (upper row) and non-inflamed contra-lateral 
joint (bottom row) of a rheumatoid arthritis patient. PA/US images in (i) show an increase 
in amplitude levels in the inflamed joint. When discarding low PA amplitudes as shown in 
(ii), only features in the inflamed joint are visible. Corresponding US/PD images are shown 
in (iii). d=dermis; dv=dorsal vein; pp=proximal phalanx; pip=proximal interphalangeal 
joint; mp=middle phalanx; s=synovium; t=extensor tendon.[15] 
Similarly, in another study for identifying inflammatory arthritis with PAI reported by 
Janggun Jo et al., SO2 values obtained from functional PAI were found to be lower in arthritis 
patients’ joints than in healthy joints[22]. In this study, 576 nm and 584 nm wavelengths laser 
pulses provided by a tunable dye laser (ND6000, Continuum) were used for imaging oxy-
hemoglobin and deoxy-hemoglobin respectively. A US platform (V1, Verasonics) 




frequency of 8 MHz were employed for data acquisition.  
1.2.2  Clinical PAI systems based on curved linear arrays 
Typically, there are two types of curved linear arrays: convex and concave. In clinical US 
applications, the convex arrays are commonly used for endo-cavity applications such as 
urology and ovary imaging due to its advantages in providing large field of view (FOV) and 
deep imaging depth[25]. On the contrary, concave arrays are more commonly used for 
increasing PA acquisition angles, such as in PA carotid imaging[20]. Clinical PAI platforms 
using concave and convex arrays are summarized in this section. 
Clinical applications based on concave arrays include imaging of breast cancer[13], 
carotid[20], vasculatures of extremities[26], and Crohn’s disease[27]. For example, in the clinical 
study on breast cancer conducted by Gael Diot et al.[13], they aimed at identifying 
photoacoustic patterns of breast cancer and noncancerous breast tissue (错误!未找到引用
源。). 10 females with malignant nonspecific breast cancer or invasive lobular carcinoma as 
well as three healthy volunteers were enrolled. The imaging system was based on the Multi-
Spectra Optoacoustic Tomography (MSOT) platform developed previously[28]. Laser pulses 
with wavelengths ranging from 700 nm to 970 nm were used to illuminate breast tissues 
consecutively. The concave array (5 MHz center frequency) employed in this study had 256 




for acceleration of real-time imaging. PA signals from four main optical absorbers including 
oxygenated hemoglobin, deoxygenated hemoglobin, lipid, and water were linearly unmixed 
to reconstruct individual component maps (错误!未找到引用源。 (c)). Their results show 
that healthy breast tissues and cancerous breast tissues have distinctive features in terms of the 
distribution of four components. Specifically, they found that total blood volume in breast 
cancers are significantly higher than total blood volume in healthy tissue, while water and lipid 
layers provide weaker contrast although these two components appear disrupted in cancerous 
tissue.  
 
Fig1.6 (a) Photograph of the handheld MSOT probe and schematic diagram of MSOT 
scanning breast tissue. (b) Hardware components for image acquisition. HS=handheld 
scanner; DAQ=data acquisition unit; PC=personal computer. (c) Normalized absorptivity 
of four main absorbers in the breast tissue.[29] 




Medical), 108 patients with Crohn’s disease were enrolled (Fig1.7)[27]. Six different 
wavelengths including 700, 730, 760, 800, 850, and 900 nm were used for PAI. Their results 
suggest that there are significant differences between active disease and nonactive disease in 
the relative concentrations of total hemoglobin, deoxygenated hemoglobin, and oxygenated 
hemoglobin. 
 
Fig1.7 (a) Schematic diagram of PAI on Crohn’s disease; (b) There is a significant 
difference in relative concentrations of total hemoglobin between patients with nonactive 
disease and active Crohn’s disease.[27]  
Besides the studies with concave linear array based on MSOT systems, other PAI clinical 
studies with concave transducers mainly include imaging of fingers[21,30]. For instance, in a 
study reported by Milan Oeri et al.[21], four arc-shaped capacitive micromachined ultrasound 
transducers (CMUT) forming a ring shape were employed for imaging human fingers. 
Compared to piezoelectric crystal normally used in traditional UST, CMUT has the advantage 




arcs and each of them consisted of eight 32-element linear CMUT arrays, while the other two 
CMUTs had smaller arcs and each of them consisted of four 32-element linear CMUT arrays. 
The central frequencies for PA reception were 11 MHz for smaller arcs and 14 MHz for larger 
arcs. Regarding to light delivery, six laser beam outputs were integrated with each arc. The 
laser source was a tunable OPO laser pumped by an Nd: YAG laser. In addition to a phantom 
study, the feasibility of the system was also tested on a volunteer finger. The results 
demonstrate that the system could provide PA microvasculature images with the FWHM 
resolution of 160 μm.  
In clinical PA/US imaging, convex arrays are mostly used for endo-cavity imaging[17,31,32]. 
The convex array usually has a large FOV because the elements are aligned divergently. 
Imaging regions of endo-cavity transducers include prostate[17], uterine cervical[32], and 
ovary[31]. Conventionally, US Doppler imaging is used to evaluate angiogenesis, an indicator 
for suspicious cancer. With the aid of PAI, higher resolution can be achieved, which may 
potentially increase diagnosis specificity. For example, in the studies conducted by Miya 
Ishihara , et al.[17,32], a micro-convex array was used for prostate cancer imaging and uterine 
cervical cancer imaging, respectively. The results demonstrate that PA signals near the tumor 
lesions may increase due to angiogenesis.  
In another study reported by Eghbal Amidi, et al.[31], researchers utilized a convex 




Systems) to image ovarian cancer. The imaging results were shown in Fig1.8. Patients were 
imaged at four wavelengths (730, 780, 800, and 830 nm). PA functional features (SO2) 
combined with PA spectrum features were analyzed with classifiers including generalized 
linear model (GLM) and support vector machine (SVM). With these two classifiers, they 
achieved an area under ROC curve (AUC) of 0.92 and 0.93, respectively in distinguishing 
benign/normal lesions from ovary cancers. As shown Fig1.8, the vascular distribution of the 
malignant ovary is more localized and intense than that in the benign lesions.  
 
Fig1.8 Co-registered total hemoglobin and US images of (a) a benign mucinous 
cystadenoma and (b) a high-grade serous carcinoma.[31] 
1.2.3  Clinical PAI systems based on volumetric arrays 
To acquire 3D volumetric PAI data from the regions of interest, a volumetric array is 
usually employed, which is composed of hundreds of UST elements aligned in a 2D or a 3D 
surface. Because PA signals usually propagate iso-tropically, the volumetric transducer with 
wide detection angle is very suitable for reception of PA signals. Different from acquisition 




capability of acquiring data from a large number of channels and high computing power to 
process 3D imaging data. The three common arrangements for UST elements of volumetric 
arrays are 2D plannar array[33-35], hemispherical array[18,36-38] and ring array[39].  
The Twente Photoacoustic Mammoscope[34] is one of the first developed systems using a 
2D plannar array. The array was made with a single 90 mm diameter circular polyvinylidene 
fluoride (PVDF) sheet. 590 independent PVDF elements with a center frequency of 1 MHz 
were achieved by activating 590 gold electrodes arranged on this PVDF sheet. A custom-made 
light delivery system comprised of prims was used for light delivery. To illuminate the whole 
imaging region, a scanning stage was used to move the delivery system in two axes Fig1.9 (a). 
In their recent upgrade systems, parallel acquisition was realized with the aid of 10 Application 
Specific ICs (ASICs) and two 8-channel 60 M Samples/s digitizers (NI PXI 5105, National 
Instruments). For an imaging area of 90 × 85 mm, it took less than 10 minutes for the data 
acquisition. The recent results shown in the study conducted by Michelle Heijblom et, al.[35] 
revealed that the Twente Photoacoustic Mammoscope was able to identify lesions in suspect 
breasts in 28 out of 29 cases. Results of magnetic resonance imaging (MRI) and correspondent 





Fig1.9 (a) Schematic diagram of the photoacoustic mammoscope.[34] (b) MR (left) and PA 
(right) cranio-caudal (CC) average intensity projections (AIP) of the breast for three cases. 
(i-ii) Patient P38, having and IDC, grade 3 of 19mm;(iii-iv) Patient P55, having and IDC, 
grade 2 of 34 mm; (v-vi): Patient P52, having an IDC of more than 50mm. The dashed box 
in the MR image indicates the area from which the PA image was acquired.[35] 
In addition to plannar 2D array, photoacoustic mammography can also be achieved with 
hemispherical array[36,37]. In the study reported by Masakazu Toi et al.[36], they employed the 
PAM-03 system developed by Canon Inc. The system was equipped with a 127 mm diameter 
hemispherical array with 512 elements (Fig1.10 (a)). The center frequency was 2 MHz and 
the bandwidth was 70%. The hemisphere was punctured to deliver the light at 755 nm and 795 
nm wavelengths provided by a Q-switched alexandrite laser. To move the transducer in a spiral 
pattern for a large FOV, the transducer was placed on a 2D motorized stage. The imaging area 
can be chosen from 50, 70, 100 mm radius. The number of acquisitions per scan also can be 
selected as 1024 or 2048. The total scan time of dual wavelengths PAI with 2048 acquisitions 
was four minutes. The results demonstrate that the PAM-03 system is capable of visualizing 




matched the overlaid MRI results Fig1.10 (b). 
 
Fig1.10 (a) Photograph of PAM-03. (b) Overlaid PAI (cyan)/MRI (red) results of a breast 
tumor lesion.[36] 
To overcome the limitation of long scanning time (~ 4 minutes) in the system presented 
by Masakazu Toi et al.[36], Li Lin et, al. developed a single-breath hold photoacoustic computed 
tomography (SBH-PACT)[39], which utilized a full-ring 512-element array as shown in Fig1.11 
(a). Combined with 1064 nm light illumination, the SBH-PACT system can achieve up to 4 
cm imaging depth and a 225 μm in-plane resolution. With the aid of four sets of 128-channel 
data acquisition systems, SBH-PACT can obtain a volumetric 3D image of the entire breast by 
fast elevational scanning within a single breath-hold (~15 s). To highlight tumor regions, they 
also developed an automatic algorithm. Tumors in all of the seven breast cancer patients 
enrolled were clearly revealed by the system. The X-ray mammogram and the depth-encoded 





Fig1.11 (a) Schematic diagram of the SBH-PACT system. (b) (i) The X-ray mammogram 
of an affected breast. (ii) The depth-encoded angiogram of the affected breasts acquired by 
SBH-PACT (iii) Maximum amplitude projection (MAP) images of thick slices in sagittal 
planes marked by white dashed lines in (ii). (iv) Automatic tumor detection on vessel 
density maps. The tumor is identified by green circles.[39] 
 
Instead of arranging hundreds of transducer elements in the form of large hemisphere or  
ring, Razansky et, al.[18] developed a real-time handheld volumetric transducer based on 
MSOT system for PAI of relatively small FOV. The array consisted of 256 piezocomposite 
elements with a 4 MHz center frequency and 100% bandwidth. These elements were arranged 
in a hemispherical pattern with 40 mm radius and 90° angle. To provide acoustic coupling, the 
cavity of the hemisphere was filled with water and sealed with transparent polyethylene 
membrane (Fig1.12). The spatial resolutions of the system were 300-500 μm along axial 
direction and 200-400 μm along lateral direction. The system was able to distinguish arteries 





Fig1.12 (a) Layout and (b) photograph of the clinical hand-held MSOT system for high 
resolution 3D imaging at video rate.[18] 
Regarding to clinical study, Sai Yee Chuah et, al. employed the MSOT system with the 
handheld volumetric transducer for skin cancer imaging[38]. Their results demonstrate that the 
system has the capability of 3D reconstruction of skin tumors in three patients with good 
histological correlation. 
1.2.4  Current challenges of clinical PAI systems 
Among current clinical PAI systems, combining conventional US systems with 
traditional US straight linear array attracts lots of interest due to its ability to provide co-
registered PA/US dual mode imaging and its operational convenience for physicians. However, 
due to limited reception angle and limited bandwidth, commercial straight linear array is not 
the most suitable one for PAI[40]. In contrast, convex transducers have a large reception angle 




of the arc can be imaged with high resolution. To overcome this challenge, Xosé Luís Dean-
Ben et al. proposed a hybrid-array-based transducer, which combined the advantage of both 
straight linear array and convex array[41]. As shown in Fig1.13, a concave array was arranged 
at two ends of the intermediate linear array. A wide FOV of 40 mm × 40 mm together with 
minimized limited-view effect was achieved. In another study, Mathias Schwarz et al. 
proposed a rotation scanning method, which can extend the receiving angles of the linear 
array[42]. 
 
Fig1.13 Suggested configuration of the hybrid PA/US imaging probe. (a) Distribution of 
the array elements in the imaging plane. (b) 3D rendering of the hybrid imaging probe, 
including the fiber bundle.[41] 
Compared with 2D PA/US imaging, 3D PA/US imaging is attractive for the ability to image the 
whole lesion and to give out a more comprehensive evaluation. A feasible way is to scan the 1-D 
linear array across regions of interest but the elevation resolution is usually poor. To address this 
issue, Yuehang Wang et al. introduced a method of placing a stainless steel slit at the front line of the 
1D transducer[43,44] as shown in Fig1.14. Their results reveal that the slit can greatly diffract the 
acoustic wave and thus increase the acoustic numerical aperture in the elevational direction. The 




four times.  
Fig1.14 (a) Schematic diagram of slit-based system. (b) Photograph of the palm of a 
volunteer. (c) Depth-encoded palm vascular image of the volunteer.[44] 
With the proposed system, rich vascular structures could be clearly seen in the PA image 
of the palm from a volunteer (Fig1.14 (c)). But the slit sacrifices the US imaging capability. 
Another challenge of using traditional US linear array for PAI is that PA signals have a 
very broad bandwidth, which can range from 1 to 100 MHz[45]. However, the bandwidth of 
traditional US linear array is very limited. The unmatched bandwidth can result the loss of 
sensitivity and spatial resolution. To overcome this issue, besides modification of traditional 
PZT transducer, another promising way is to use capacitive micromachined ultrasound 
transducers(CMUT)[21,45,46]. The CMUT transducer has wider detection bandwidth than 
traditional PZT transducers. As mentioned earlier, Milan Oeri et al. reported a system using a 
CMUT array with 15 MHz bandwidth for detection of inflammatory arthritis in fingers[21]. 
To summarize, with the potential of evaluating cancers and other diseases, PAI has been 
intensively studied clinically. In this section, several representative clinical PAI studies based 




systems are also discussed. Although PAI has shown its great potential in multiple clinical 
applications, to add considerable values to the clinical diagnosis, its clinical efficacy still needs 
to be further verified with large-scale clinical studies. Besides, a versatile PAI to multiple 
clinical applications is also of vital importance considering the cost-effectiveness. 
1.3  The outline of this thesis 
In this thesis, the author first introduced the mechanism of PAI, and reviewed several 
representative clinical PAI systems reported so far in the first chapter.   
Next, in the second chapter, the development of PA/US dual mode imaging system is 
presented. The imaging ability of the system was verified with both of the phantom study and 
the in vivo study. In the third chapter, the author first reviewed the concept and the necessity 
of optical fluence compensation in PAI. After then, the proposed method of fluence 
compensation for hand held PA/US imaging is introduced. The effectiveness of the proposed 
method was first verified on a tissue mimicking phantom and then verified on the breast tissue 
in vivo. After then, in the fourth chapter, the clinical study of PA/US imaging on thyroid cancer 
is presented. PAI results of thyroid cancer was compared with traditional US Doppler imaging.  
In the fifth chapter, the updated PA/US imaging system with the ability of 3D PA/US 
functional imaging is introduced first. The clinical study of 3D PA/US functional imaging on 




differentiating malignant tumors from benign ones, 3D PA/US imaging results of breast 
tumors were analyzed.  
After then, in the sixth chapter, the author introduced the research conducted in Georgia 
Institute of Technology. The aim of this research was to compare the differences between 
surface acoustic waves induced by laser excitation and surface acoustic waves induced by 
acoustic radiation force. Ultrafast US imaging was used for tracking wave propagations in 
both of excitation methods. Differences were investigated in terms of propagation velocity and 
frequency spectrum. The relationship between laser-induced shear wave amplitude and optical 
fluence was also investigated.  
In the final chapter, the author concluded the novelty of this thesis and discussed the 





CHAPTER 2  PA/US DUAL MODALITY IMAGING BASED ON 
HANDHELD CLINICAL ULTRASOUND 
PA/US dual modality imaging based on handheld clinical ultrasound has been studied by 
several institutes due to its feasibility in clinical imaging process. In this chapter, our self-
developed PA/US dual mode imaging system based on a handheld clinical ultrasound is 
presented first. Then, the imaging ability of the developed system is demonstrated through the 
phantom study and the in vivo study on the human forearm. 
2.1  PA/US dual mode imaging system 
The PA/US dual modality system was developed based on a high-end commercial clinical 
US system (Resona7, Mindray Bio-Medical Electronics Co., Ltd., China)[47] (Fig2.1). The 
system was able to perform all US imaging functions and had the ability to perform parallel 
data acquisition, which was required by PAI. When performing PAI, the system worked on 
receiving-only mode. A 192-element clinical linear probe with a center frequency of 5.8 MHz 
(L9-3U, Mindray Bio-Medical Electronics Co., Ltd., China) was employed for PA/US imaging. 
The laser source was a Q-switched Nd: YAG laser (LS-2137/2, LOTIS TII, Minsk, Belarus). 





Fig2.1 Schematic diagram of the PA/US dual mode imaging system[47] 
The parameters of our system have been summarized as the following table: 
Table2.1  Detailed information of our PA/US dual mode imaging system 
Ultrasound 
system 
Model Resona 7, Mindray 
Sampling rate 50 MHz 











Element numbers 192 









Wavelength 1064 nm 
PRF 10 Hz 
Pulse duration 10 ns 
 
For light delivery, we customized a one-two bifurcate optical fiber bundle from Nanjing 
Chunhui Science and technology Industrial Co. Ltd as shown in Fig2.2. The size of the fiber 
head was 46 mm×25 mm to match the size of the probe. 
 
Fig2.2 Customized fiber head to match the size of the probe. 
To stabilize the fiber bundle along the two sides of the probe, a holder was designed and 







Fig2.3 Schematic diagram of the PA/US dual mode transducer. 
The angle between the fiber head and the transducer was set to be 45° to make sure that 
the light bands from two optical fibers were close enough on the surface of the imaging target 
for high imaging contrast.  
Besides, the shape of the dual mode probe was also within our consideration. For 
handheld probe, the size should be controlled to make sure it was easy to use when performing 
imaging especially in clinical studies. To allow light illuminating onto the surface of the 
imaging area below the transducer, we put a transparent soft gel pad between the probe and 
the imaging surface.  




made of silica gel and TiO2 particles was placed at the front surface of the transducer. To make 
this film, we first mix the TiO2 particles together with silica gel on a piece of glass. After then, 
we used another piece of glass to flatten the semi-solid mixture to make sure the mixture 
becomes an even layer as thin as possible.  
After drying for 24 hours, the mixture would become a membrane, which we could then 
peel off from the glass. The aim of placing this white film was to avoid unwanted PA signals 
generated by the grey surface of the transducer.  
The film was tested with ultrasound imaging and the acoustic attenuation inside the film 
was acceptable for both PAI and US imaging. 
 




To make sure the optical fluence on the skin surface was well below the ANSI 
recommendation for maximum permissible exposure (MPE) at 1064 nm, which is 100 
mJ/cm2[48], we first measured the area of illumination with the CCD camera as seen Fig2.5. 
The CCD was focused at the front surface of the gel pad during the acquisition of images. 
 
Fig2.5 System setup for measurement of illumination area 
After obtaining the illumination area (as shown below), which was 10 cm2, we adjusted 
the pulse energy to make sure that the optical fluence is within ANSI limitation[48]. and the 





Fig2.6 Illumination area of the fiber bundle on the front side of the probe. 
To guarantee that PAI and US imaging were performed on the same area, 500 μs after US 
imaging, the data acquisition system sent out a trigger signal to the laser to trigger the laser 
pulse. This delay can also make sure that the US signals will not affect acquisition of PA signals. 
A photo diode placed near the output of the laser source was used to provide synchronization 
signals for PA data acquisition (see Fig2.7). The reason we used the photodiode was that we 
found the delay between Q-switch trigger out signal of the laser system and laser illumination 
varied from pulse to pulse. After the acquisition of PA signals, PA images were reconstructed 
with the delay and sum algorithm and were co-registered with US images. For this version of 
the dual mode imaging system, it was not capable of reconstruction of PA images online. To 
improve the signal to noise ratio (SNR), each PA image was averaged five times and thus the 
total acquisition time for one PA/US dual mode frame was one second given that the PRF of 
laser pulse was 10 Hz. To further improve the SNR, a band-pass filtering centered at 5.5 MHz 





Fig2.7 Work flow of data acquisition for PA/US dual mode imaging 
2.2  Phantom study for validation of the PA/US imaging ability of the system 
To validate the performance of the system and the reconstruction algorithm, we did 
phantom experiments with a carbon rod[47]. The system setup can be seen in Fig2.8.  
The carbon rod had a length of 3 cm and a diameter of 0.5 mm. To mimic the optical 
properties of tissue, the carbon rod was immersed into the solution of 1% intralipid. The carbon 
rod was first set at different inclination angles including 30°, 15°, and 0° to test the imaging 
ability of the system with PA signals from different directions. Besides, we also adjusted the 
depth of the carbon rod to test the imaging ability of the system at different depths. All PAI 
results were shown in linear a scale, and a threshold of 8% of the maximum PA signals was 





Fig2.8 System setup for phantom study with the 2D PA/US imaging system 
From the PA/US imaging results of the carbon rod at different angles of inclination 
(Fig2.9 (a)-(c)), we could see that the shape and the position of the carbon rod shown in PAI 
were well matched with those shown in US imaging. These results demonstrated that the 
system was capable of performing PA/US dual mode imaging. Besides, we could also see that 
PA signals decreased with the increase of the inclination angle. This was due to the fact that 
the PA waves generated from the carbon rod propagated in the direction that was perpendicular 
to the surface of the carbon rod. Because the linear array has a limited reception angle, the 
sensitivity of the transducer decreases when the relative angle between the propagating 




amounts of PA signals were received by the transducer when the inclination angle of the carbon 
rod increased.  
PAI results of carbon rods at different depths were shown in Fig2.9 (d-f). We could see 
that due to the attenuation of the optical fluence at deeper regions, amplitudes of PA signals 
decreased when the imaging depths increased.  
 
Fig2.9 Dual-modality imaging results of a carbon rod hanged in intralipid solution with 
different orientation angles (a-c), and different depths (d-f). US results are in gray, and PAI 
results are in pseudo-color (color bar shown at right).[47] 
2.3  In vivo study on the forearm of a healthy adult 
After validating the imaging ability of the PA/US dual mode imaging system with the 




healthy adult[47]. The protocol of this study was approved by the institutional ethics committee 
of Peking Union Medical College Hospital. 
First, we imaged the vein in the forearm of the healthy volunteer with the probe parallel 
to the vein. In addition to PA/US dual mode imaging, pure US imaging results and color 
Doppler flow imaging (CDFI) results of the same region were acquired for comparison. After 
then, we rotated the transducer to image the cross section of the vein. The imaging results 
where the probe was parallel to the vein were shown in Fig2.10 (a)-(c), and the imaging results 
of the cross section of the vein were shown in Fig2.10 (d)-(f). 
From CDFI results shown in Fig2.10 (a) and (d), the vein structure and the blood flow 
were clearly revealed. PAI results in color scale were overlaid with US imaging results (grey 
scale) as shown in Fig2.10 (c) and (f). The upper wall of the vein shown in PAI results were 
well matched with the upper wall shown in US imaging results and CDFI results. Additionally, 
we could also see PA signals from the skin due to the strong optical absorption of melanin in 
skin cells. It was worth noted that due to the large size of the imaged vein and the strong 
absorption of the blood, much of the light was absorbed before it went deeper into the vein. 
As a result, the upper wall of the vein showed up more clearly than the bottom wall in PAI 
results. Additionally, due to the limited reception angle of the linear array[49], the two side walls 





Fig2.10 Imaging results of human forearm cutaneous vein with longitude section and 
transverse sections. (a) CDFI result with longitude section; (b) gray scale US B-scan with 
longitude section; (c) PA/US imaging with longitude section; (d) CDFI result with 
transverse section; (e) gray scale US B-scan with transverse section; (f) PA/US imaging 
with transverse section;[47] 
2.4  System development of 3D PA/US imaging system 
After we verified the imaging capability of 2D PA/US imaging system. We moved 
forward to system development of 3D PA/US imaging system. Instead of reconstruction of 
PAI results offline, the updated system was able to perform real time imaging at 10 Hz, which 
was essentially limited by the PRF of laser system. Additionally, for functional PAI, we 
replaced the Nd: YAG laser with a tunable OPO laser, which can generate laser pulse at 
wavelengths from 700 to 850 nm at 10 Hz. There was a power meter inside the OPO laser, 
which was placed near the output of laser light. For functional PAI, we normalized each frame 
with the energy measured at that pulse. Normalization is of vital importance especially for 
functional imaging, where the optical absorption coefficient was linear to PA signals 




Table2.2  Detailed information of our 3D PA/US imaging system 
Ultrasound 
system 
Model Resona 7, Mindray 
Sampling rate 50 MHz 





Delay and sum 
Imaging speed 10 Hz 
Transducer 
Model L9-3U 
Element numbers 192 
Center frequency 5.8 MHz 




Innolas laser GmbH 
Wavelength 700-850 nm 
PRF for functional PAI 5 Hz 
Pulse duration 10 ns 
For 3D imaging, we designed a 3D scanning device as shown in Fig2.11. In this 
photograph, a human forearm lay below the 3D scanning device to indicate the location of 
imaging target for 3D imaging. .During the 3D imaging, we placed the 2D linear array used 




a set of 2D PA images and US images were acquired in turn. The total scanning length was 4 
cm. With an PRF of 5 Hz for functional PAI, the total frame number for each imaging modality 
after one scanning was 200. 
 
Fig2.11 Photograph of the 3D imaging device 
The photograph of the 3D PA/US functional imaging system was shown below: 
 




2.5  Summary 
In this chapter, the development of the 2D PA/US imaging based on a high-end clinical 
ultrasound system is presented. Particularly, the system parameters, the setup for laser delivery 
as well as the workflow of data acquisition are introduced. The imaging capability of the 
system was verified by both of the phantom study and the in vivo study. The imaging results 
demonstrate that our self-developed 2D PA/US imaging system is able to perform PA/US dual 





CHAPTER 3  OPTICAL FLUENCE COMPENSATION FOR 
HANDHELD PA/US DUAL MODALITY SYSTEM 
Due to the optical absorption and scattering in tissue, optical fluence decays quickly as 
depth increases. Because the initial PA pressure is dependent on the product of the local fluence 
and the optical absorption coefficient, it is important to perform fluence compensation 
especially for quantitative PAI[50]. Although PA/US dual mode imaging with handheld probes 
have been investigated in previous studies[26,51], few research has been carried out on fluence 
compensation based on handheld PA/US dual mode imaging systems. In this chapter, the 
author first reviewed current methods for optical fluence compensation including Monte Carlo 
simulation and diffusion theory. Next, an optical fluence compensation method for the 
handheld PA/US imaging system was developed based on diffusion theory. After then, the 
proposed fluence compensation method was applied to PAI results from the tissue mimic 
phantom and the human breast. The comparison between PAI results before and after optical 
fluence compensation demonstrated that the proposed method was able to effectively improve 
the imaging quality especially in deeper tissue. 
3.1  Introduction to the optical fluence compensation for PAI 
According to the mechanism of PA effect, the initial PA pressure 𝑝0 can be calculated 








𝐴(𝒓) = Γ𝐴(𝒓) (3.1) 
where 𝑣𝑠  is the sound speed, 𝛽  is the volume thermal expansivity, 𝐶𝑝  is the constant 
pressure specific heat capacity, and A is the absorbed energy density (specific optical 
absorption). Γ is the Grüeneisen coefficient, which represents for efficiency of the conversion 
of heat to pressure. 𝐴(𝒓) can be calculated by the product of the absorption coefficient 𝜇𝑎 
and the optical fluence 𝐹 at point 𝒓 as shown in Eq. (3.2). 
 𝐴(𝒓) = 𝜇𝑎(𝒓)𝐹(𝒓) (3.2) 
In general, the Grüeneisen coefficient Γ is constant in PAI. Thus based on Eq. (3.1) and 
Eq. (3.2), the initial pressure 𝑝𝑜(𝒓) is proportional to the product of 𝜇𝑎(𝒓) and 𝐹(𝒓). Due 
to the strong optical scattering and absorption of tissue, 𝐹(𝒓) is nonuniform. Hence, the 
distribution of absorption coefficient 𝜇𝑎(𝒓)  could not be accurately represented by the 
reconstructed initial pressure 𝑝𝑜(𝒓) from original PA signals. Specifically, in deeper tissue, 
imaging contrast can decrease significantly because 𝐹(𝒓) decreases greatly. 
However, if the optical parameters of the tissue are known, one can calculate the optical 
fluence by solving the photon diffusion equation using the finite element method[52,53] or by 
numerically simulating photon transport with Monte Carlo method[2]. Both of these two 
methods depend on the assumption that photons propagating through tissue can be treated as 




Carlo method, no additional assumptions are required. The trajectory of a photon is modeled 
as a persistent random walk. The direction of each step depends on the direction of the previous 
step. Given the optical properties of tissue, optical fluence can be estimated by tracking a 
sufficient number of photons. Although the accuracy of Monte Carlo simulation has been 
tested experimentally, it requires tracing a large number of photons to obtain an acceptable 
variance and thus is computationally heavy[55]. Different from the Monte Carlo simulation, 
diffusion theory is based on solving the diffusion equation. The diffusion equation is the 
approximation of radiative transfer equation (RTE). RTE is considered equivalent to the 
numerical Monte Carlo method and is difficult to solve, thus the diffusion equation is 
employed to obtain a fast solution[2]. The additional condition required by the diffusion theory 
is that the scattering coefficient in tissue is much larger than the absorption coefficient[56]. 
Although the diffusion theory is less accurate than the Monte Carlo simulation, it is much 
more computationally efficient[2]. It should also be noted that although the diffusion theory 
provides a fast approach to simulating fluence distribution, it is not valid near the photon 
source.  
In the study presented in this chapter, the diffusion theory was applied to perform fluence 
compensation for the following reasons: 1) The interested area in PA/US dual mode imaging 
is beyond several millimeters depth, thus the analysis in the super shallow region of the tissue 




effective. Hence, it’s more appropriate for clinical study, where shorter imaging time can 
increase diagnosis efficiency. After the optical fluence distribution is known, the relative 
absorption coefficient 𝜇𝑎(𝒓) can then be calculated from Eq. (3.2) through dividing the 
original PA signals by local fluence values. 
3.2  Optical fluence compensation on tissue mimicking phantom 
To evaluate the performance of the proposed compensation method, we first did a 
phantom study[57]. Two 0.6 mm diameter carbon rods were placed in an agar phantom to 
provide the optical absorption. The agar phantom was made up of three layers. Both of the 
first layer and the second layer were made of cuboid agar phantoms with intra lipid (IL) added, 
while the third layer was made of pure agar phantom. The IL added in the first layer had a 
weight concentration of 3.3% and the IL added in the second layer had a weight concentration 
of 1.8%. According to the reduced optical scattering coefficient of 0.1% IL, which was 
measured to be 0.832 cm-1 at 1064 nm wavelength, the reduced optical scattering coefficient 
of the first layer and the second layer were 27.5 cm-1 and 15.0 cm-1, respectively. Because the 
main absorptive component of the agar phantom was water, the absorption coefficients of the 
first layer and the second layer were treated as same with water, which was 0.12 cm-1[58] at 
1064 nm. After preparing the phantom, we used the PA/US dual mode imaging system 
described in Chapter 2 to image the phantom with both US mode and PA mode. The angle 




pad was placed between the surface of the phantom and the surface of the transducer to allow 
light illuminating directly on the phantom surface below the transducer. Both of the gel pad 
laser and the bottom pure agar layer were considered optical transparent mediums. The 
schematic diagram of the imaging setup is shown in Fig3.1. 
 
Fig3.1 The schematic diagram of imaging setup and three layers.[57] 
The schematic of the imaging system was shown in Fig3.2. The laser source was an 
Nd:YAG laser which can generate 1064 nm wavelength laser pulse at 10 Hz. The imaging 
transducer we used had a center frequency of 5.8 MHz, which had an imaging depth beyond 
4 cm. The system we used was based on Mindray Resona 7, the detail of which has been given 





Fig3.2 The schematic of the imaging system for the phantom study 
To obtain the fluence map in the imaging area based on diffusion theory, we performed 
the numerical simulation to solve the diffusion equation with COMSOL (COMSOL Inc., 
Sweden). The shapes of the two layers of the phantom with intra lipid added were assumed to 
be two cuboids in the COMSOL simulation (see Fig3.3). The phantom was modeled as a 
cuboid in our COMSOL simulation. The horizontal size was set to be 162 mm, which matched 
the size of the phantom itself. Additionally, the large horizontal size can make sure that the 
optical fluence decreased to zero at side boundaries. As a result, the boundary condition of the 
four lateral sizes can be set to zero fluence at COMSOL simulation. The red part shows the 





Fig3.3 The shapes of two layers of the phantom with intra lipid added were assumed to be 
two cuboids in COMSOL simulation.[57] 
As shown in Fig3.3, in the diffuse approximation, the light source was equivalent to two 
bands lying 𝑑𝑧 beneath and parallel with the phantom surface with the setup shown in Fig3.1, 
where 𝑑𝑧 can be calculated from Eq. (3.3): 
 𝑑𝑧 = 𝑙𝑡
′cos31∘ (3.3) 
Here, 𝑙𝑡
′ = 0.19𝑐𝑚 was the transport mean free path in the first layer. Each band had a 





2Φ + Φ = 0 (3.4) 
where 𝜇𝑒𝑓𝑓  is the effective attenuation coefficient, Φ  is the fluence rate. 𝜇𝑒𝑓𝑓  can be 




 𝜇𝑒𝑓𝑓 = √𝜇𝑎/𝐷 (3.5) 
The diffusion coefficient 𝐷 is related to the absorptive coefficient 𝜇𝑎, the reduced scattering 
coefficient 𝜇𝑠
′  according to Eq. (3.6) 




′ )) (3.6) 
Because that the refractive index of the gel pad was similar to that of the phantom, and the 
refractive index for each layer of the phantom was nearly the same, the boundary between gel 
pad layer and the boundary between each layer of the phantom were treated as refraction-
index-matched ones[2] as shown in Eq. (3.7), 
 Φ(𝒓) − 2𝐷∇Φ(𝒓) ∙ 𝒏 = 0 (3.7) 
with 𝒏 representing for the unit normal vector of the boundary pointing into the phantom 




2 ∇Φ ∙ 𝒏 = 𝑆 (3.8) 
Here, 𝑆 was the optical source. Because the dimension of the cuboid was large enough for 
the optical fluence to attenuate to zero at the side boundary, the boundary conditions of these 
four side walls were set to be zero fluence. After solving the diffusion equation with COMSOL 
simulation, we obtained the map of optical fluence rate at the imaging plane as shown in Fig3.4. 




the increase of depth after 1 cm. Besides, we could also learn that, the optical fluence also 
decreased when the locations were away from the center region. 
 
Fig3.4 Optical fluence rate map of the central cut plane.[57] 
Next, we divided the original PAI result of the phantom with the optical fluence rate map 
obtained above to achieve the optical fluence corrected PAI result according to Eq. (3.2). The 
original PAI result, the optical fluence corrected PAI result, and the US imaging result of the 
phantom were shown in Fig3.5. Before the optical fluence compensation, only the carbon rod 
in the top layer of the phantom showed up (Fig3.5 (a)), and the carbon rod in the second layer 
of the phantom could hardly be seen. After the optical fluence compensation (Fig3.5 (b)), the 
carbon rod in the second layer of the phantom was as clear as the carbon rod in the first layer. 
US imaging results (Fig3.5 (c)) verified that the location of the second carbon rod was 
correctly reconstructed. It should also be noted that some noise signals were also amplified 





Fig3.5 (a) (b)PA images of phantom without and with optical fluence compensation; (c) US 
images of the same phantom.[57] 
To quantitatively evaluate the proposed optical fluence compensation method, we 
compared the normalized values before and after compensation as shown in Table3.1. 









1 3.0 1 1 
2 14.5 0.142 1.30 
Before the optical fluence compensation, the PA signal coming from the carbon rod 2 was 
only around tenth of the carbon rod 1. Theoretically, the absorption coefficients of these two 
carbon rods are same and thus after optical fluence compensation, PA values from two carbon 
rods should be same. From the above table, we could see that the corrected PA value of the 
bottom carbon rod was much closer to the PA value of the upper carbon rod. These results 
demonstrate that the proposed optical fluence compensation method is able to improve the 
imaging quality in deeper regions of the tissue-mimic phantoms. From quantitative analysis, 




before and after compensation was nearly 86%, while after optical fluence compensation, this 
difference decreased to only 30%, suggesting that our optical fluence compensation strategy 
has the potential to reveal deeper information. However, it should be noted that, the optical 
absorption coefficient from the carbon rod at the first layer and the second layer should be 
same. Thus, the PA signals after compensation should be exactly same with the PA signals 
before compensation. There might be several potential reasons why PA signals after 
compensation was not good enough. First, when setting optical parameters in the phantom, we 
might induce some errors, which may as a result, affect the accuracy of the optical fluence 
compensation. Second, it could be seen from our US imaging results that there were several 
scattering objects distributed randomly at the first layer. This can affect the both of the fluence 
compensation in COMSOL and the acquisition of PA signals. 
3.3  A preclinical study with the optical fluence compensation applied 
In the following preclinical study, we applied the proposed optical fluence compensation 
method to the PAI results of a healthy breast[57]. The protocol of this study was approved by 
the institutional ethics committee of PUMCH. PA/US dual mode imaging was carried out to 
obtain the PA/US imaging results of a healthy breast from a 47 years old woman with the 
PA/US dual mode imaging system introduced in Chapter 2. A 4 mm gel pad was placed 
between the breast surface and the transducer surface to allow the light illuminating directly 




and the imaging plane was 30°. As mentioned before, the set of angles between illumination 
direction and the imaging plane should be considered with the total size of the probe. For the 
application in this study, because that the imaging target is human breast, the size of the probe 
should be small enough so that physicians can hold it very easily. As a result, the angle was 
adjusted from 45° in phantom study to 30° in this clinical study. The laser source was a Q-
switched Nd: YAG laser (LS-2137/2, LOTIS TII, Minsk, Belarus) and could generate 1064 nm 
laser pulses at 10 Hz. At these wavelengths, the light can penetrate much deeper than at other 
wavelengths such as NIR region. The imaging contrast in tissue at this wavelength mainly 
comes from blood, where the oxygenated hemoglobin and deoxygenated hemoglobin are the 
main component and have strong absorption coefficients. 
The breast tissue was assumed to have two layers including the skin layer and the breast 
adipose layer. This simplification was used because, first, the tissue components in breast is 
relatively simple, where most was adipose. Second, the skin layer was set because the skin 
layer has a very different optical parameters than other types of tissue. The absorption 
coefficient of skin layer can be ten times of other types of tissue, such as adipose. Besides, we 
also referred to US imaging results of the breast in this study when setting multilayer models 
for COMSOL simulation. Based on our US imaging results, the breast tissue also mainly 
concludes the skin layer which was around 3 cm thick, and the adipose layer. 




breast area by US imaging to obtain the structure of the imaged area. Similar with the phantom 
study introduced in the previous section, we performed the proposed optical fluence 
compensation method by numerical simulation with COMSOL (COMSOL Inc., Sweden). In 
the COMSOL simulation, the breast was treated as a semi-infinite medium for two reasons: 1) 
the footprint of the transducer was around 4 cm length, which was much smaller than the 
breast; 2) The optical fluence decreases quickly as the imaging depth increases.  
 
 
Fig3.6 (a) The shape of breast tissue was assumed to be a cuboid, (b) The schematic 
diagram of the detection setup.[57] 
As shown in Fig3.6 (a), the breast was modeled as a cuboid with a dimension of 200 mm 
× 200 mm × 154 mm in COMSOL. The cuboid consisted of three layers: a 4 mm-thick gel 




diagram of the imaging setup for this model is shown in Fig3.6 (b)[57]. The absorption and 
scattering coefficients of the transparent gel pad layer were all set to be zero. Based on 
previous studies, the skin layer has an absorption coefficient of 𝜇𝑎1 = 0.1 𝑐𝑚
−1and a reduced 
scattering coefficient of 𝜇𝑠1
′ = 10 𝑐𝑚−1[59], respectively. The adipose layer has an absorption 
coefficient of 𝜇𝑎2 = 0.091 𝑐𝑚
−1 and a reduced scattering coefficient of 𝜇𝑠2
′ = 6 𝑐𝑚−1 [60], 
respectively. 
In the diffuse approximation, the light source is equivalent to two bands lying 𝑑𝑧 
beneath and parallel with the skin surface, which can be calculated as 
 𝑑𝑧 = 𝑙𝑡
′ × 𝑐𝑜𝑠21° (3.9) 
where 𝑙𝑡
′ = 0.1 𝑐𝑚 was the transport mean free path, and 21° was the incident angle on skin 
surface due to the light refraction from air to the gel pad. The dimension of each band was 5 
cm × 1 cm. Similar with the equations applied in the phantom study, the diffusion equation for 
the breast region was set to be Eq. (3.4), and the source condition of two light bands was Eq. 
(3.8). The boundary condition between the gel pad layer and the skin layer was set to be Eq. 
(3.7) because the refractive index of the gel pad was similar to the refractive index of tissue. 
Since the distances from the optical source to the other surfaces of the model were large 
enough for optical fluence to attenuate to zero, boundary conditions of the four side walls and 




cuboid was meshed into free tetrahedral elements. The element size was set to be extra fine 
defined by COMSOL to balance the computational efficiency and the simulation accuracy. 
The cuboid was segmented into 1012184 elements in total. After solving the diffusion equation 
in COMSOL, we obtained the optical fluence rate of the cuboid. The optical fluence rate map 
in the imaging plane was shown in Fig3.7 (a). The fluence rate variance along the centerline 
(dashed line shown in Fig3.7 (a)) was plotted in Fig3.7 (b). From the fluence rate variance 
curve, we could see that with the imaging setup in this study, the maximum fluence rate 
appeared at the depth of 5 mm approximately. 
 
Fig3.7 (a) Relative fluence rate map at the central cut plane. (b) Relative fluence rate along 
the dark dotted line in (a).[57] 
To compare the change of optical fluence along depth more intuitively, we plotted the 
relative fluence rate along the dark dotted line in Fig3.7. We could see that the maximum of 
the optical fluence rate showed up at around 5 mm. After then, the optical fluence decreased 
quickly and only to one thirds of the maximum at the depth of 19 mm. This difference between 




Because the functional PAI was closely related to PA signals normalized by local fluence. 
Without fluence compensation, it would be hard to restore absorption coefficients, which are 
contributed from the product of the concentrations and the molar extinction coefficients of 
photoabsorbers.  
 
Fig3.8 Relative fluence rate along the dark dotted line in Fig3.7[57]. 
The relative fluence rate map shown in Fig3.7 (a) was then applied to compensate the 
PAI results according to Eq. (3.2). The imaging results before and after compensation were 
shown in Fig3.9. The original PA image was shown in Fig3.9 (a). Because the main optical 
absorptive component at 1064 nm in tissue is blood, the primary PA sources in the breast are 
vessels. From Fig3.9 (a), we could see four vessels at different depths marked with white 
dashed circles values. Due to the attenuation of optical fluence in deeper tissue, the PA signals 




the original PAI result with the fluence rate map (Fig3.7 (a)), we obtained the fluence corrected 
PAI results as shown in Fig3.9 (b). PAI results before and after compensation were both 
normalized to their maximum values. 
 
Fig3.9 (a) PAI results of a healthy breast without optical fluence compensation. (b) PAI 
results of the breast with optical fluence compensation.[57] 
Table3.2 summarized the normalized PA values of the marked four vessels before and 
after compensation. 
Table3.2 Comparison of PA values before and after compensation[57] 








1 3.0 1 1 2.7379 
2 7.3 0.8386 0.8971 2.5749 
3 9.6 0.3428 0.4300 2.1830 
4 14.4 0.1172 0.2908 1.1031 
From the above table we could see that PA values of the reconstructed vessels in deeper 




by around ten folds and became much more prominent in Fig3.9 (b). 
For the PA/US dual mode imaging in this study, 15% of the maximum value of PA signals 
was set as the threshold. Fig3.10 (a) and Fig3.10 (b) showed the PA/US dual mode imaging 
results before and after optical fluence compensation respectively.  
 
Fig3.10 (a) PA/US dual mode imaging result without compensation of optical fluence. (b) 
PA/US dual mode imaging result with compensation of optical fluence. 
Similar with pure PAI results, PA signals from vessels in deeper regions were much 
weaker and can be missed before the fluence compensation. However, it should also be noted 
that the noise signals in deeper regions were also amplified after the optical fluence 
compensation (see scattered patterns in the left bottom of Fig3.10 (b)). 
3.4  Summary and discussion 
In this chapter, we proposed an optical fluence compensation method for the handheld 
PA/US dual mode imaging system. The proposed method was based on the diffusion theory 
and was performed with COMSOL simulation. We first verified our method with the phantom 




healthy breast tissue. The comparison of PA signals before and after the fluence compensation 
reveals that the proposed method could restore more PA sources especially in deeper regions. 
However, it should be noted that the proposed method is still based on a simplified model. 
For example, the skin surface in the US imaging is not as even as the simplification model. To 
apply the method for real tissue imaging, more factors need to be considered. For example, 
breasts and other organs usually consist of different types of tissues including fat, muscle, 
water, etc. Thus, to obtain an accurate optical fluence map, optical parameters from different 
types of tissues should be included in the simulation model. US imaging can aid in obtaining 
more information of tissue types in imaging regions.  
It also should be mentioned that, for the fluence compensation strategy in this study, the 
main challenge is to identify the optical parameters of real tissue. This can change from case 
to case. Besides, although US can provide anatomy information, sometimes it is still hard to 
identify every type of tissue with pure US imaging. In this case, approximating optical 
parameters based on previous studies is necessary, although this may include errors. 
The uncertainty of the optical parameters of the imaged targets could also generate errors 
in functional PAI even after optical fluence compensation. For example, the calculation of SO2 
is very sensitive to the optical fluence and thus very sensitive to the optical absorption and 




the absolute difference is important. Thus, when performing functional PAI, one potential 
method to increase the accuracy for calculation of concentrations of the photo-absorbers is 
utilizing wavelengths where the optical absorption and scattering are similar is important 
Besides, the proposed method was only applied to 2D imaging in this study. In the future, 
it could also be extended to 3D PA/US imaging. It should be noted that the optical properties 
of the same type of tissue can also vary, which increases the difficulties in obtaining an 
accurate fluence map of real tissue. Finally, the noise signals in deeper regions are amplified 
as well after the fluence compensation. Thus, the distinguishing between real PA signals and 
the noise signals is also important to improve the imaging quality in deeper tissues. 
In conclusion, our study demonstrates that based on the anatomy information provided 
by US imaging, the proposed optical fluence compensation method could aid in regaining 
important information from deeper regions in PA/US imaging. In the future, the proposed 
method can potentially be applied to quantitative PAI, where the accurate calculation of 





CHAPTER 4  AN INITIAL CLINICAL STUDY OF THYROID CANCER 
WITH HANDHELD PA/US IMAGING SYSTEM 
A clinical study of human thyroid with PA/US dual mode imaging is presented in this 
chapter. We imaged both healthy and cancerous thyroids and compared PAI results with color 
Doppler US imaging results. PAI of thyroids revealed more blood vessels than color Doppler 
US imaging, demonstrating that PAI could provide important complementary information to 
traditional US examinations of thyroids. 
4.1  Background 
As an endocrine gland, thyroid is located at the front of neck and consists of two 
connected lobes. The primary function of the thyroid is to produce hormones that regulate 
body’s metabolic rate, heart and digestive function, brain development, etc. Thyroid nodules 
are solid or fluid-filled lumps that form within thyroids. Only a small percentage of thyroid 
nodules are cancerous, with the malignant cases of all the discovered thyroid nodules being 
around 10%[61]. The malignant cases of thyroid nodules mainly include papillary thyroid 
cancer and follicular cancer[62]. The treatment of thyroid nodules highly relies on the early 
detection of malignant cases with high accuracy[63]. 




Thyroid Association (ATA) guidelines[61]. To further improve the diagnosis accuracy of thyroid 
cancer, novel imaging techniques have emerged recently. For example, shear wave 
elastography and contrast-enhanced ultrasound (CEUS) have been investigated for evaluation 
of thyroid nodules[64,65]. Although these new imaging techniques have shown great potential 
in diagnosis of thyroid nodules, they still have limitations. For example, shear wave 
elastography can reveal the stiffness information of the thyroid nodules but cannot provide 
functional information such as micro-vascularization of thyroid carcinomas. CEUS can 
provide micro-vascularization information of thyroid cancers but is invasive due to the 
requirements of the intravenous injection of contrast agents. Thus, noninvasive imaging 
modalities, with the capability of providing morphological, structural and microvascular 
information are highly desired for the diagnosis of thyroid cancer. 
In the following study, we carried out a preclinical study of thyroid cancer with the self-
developed dual-mode PA/US imaging system[47]. Both of the healthy and cancerous nodules 
were imaged with PA, US and color Doppler US imaging modalities. By comparing PAI results 
with the US imaging and the color Doppler US imaging results, we found that PAI could 





4.2  System setup 
The system employed in this study has been introduced in Chapter 2. As seen in Fig4.1, 
the PA/US dual mode system was based on a high-end ultrasound imaging system (Resona 7, 
Mindray Bio-Medical Electronics Co., Ltd., China), which was capable of performing parallel 
data acquisition while preserving all US imaging functions including color Doppler imaging. 
The transducer used for receiving US and PA signals had 192 elements with a center frequency 
of 5.8 MHz. When performing PAI, the system was set in the receiving-only mode. The laser 
source was an Nd: YAG laser, which could generate 10 Hz laser pulse at 1064 nm. At 1064nm, 
the main absorptive component in tissue is hemoglobin. The laser was triggered 500 μs after 
the US imaging to make sure that the US signals in US imaging did not affect PA signals 
acquisition. A customized fiber bundle together with a 3D-printed holder were used for light 
delivery. A gel pad was placed between the transducer surface and the skin surface to make 
sure that light can illuminate directly onto the skin surface underneath the transducer. To avoid 
unwanted PA signals generated from the transducer surface, we made a thin film made out of 
silica gel and TiO2 to cover the transducer surface. The optical fluence on the skin surface was 
measured to be 5.5 mJ/cm2, well below the ANSI recommended maximum permissible 
exposure (MPE), which is 100 mJ/cm2 for 1064nm. PA images were reconstructed with the 
delay and sum algorithm, and each PA image was averaged by 5 frames to improve the SNR. 




Because the reconstructed PA values had a large dynamic range, which was around 30 dB, the 
PA images were presented in log scale. To suppress the noise level, we set a threshold of 10% 
of the maximum reconstructed PA values. 
 
Fig4.1 (a) Schematic diagram and (b) photograph of the PA/US dual mode imaging 
system.[47] 
4.3  Patients enrollment and PA/US imaging procedure 
Patients for the preclinical study were enrolled from the outpatients and inpatients of 
surgery department at Peking Union Medical College Hospital (PUMCH) from Dec. 15th, 2016 
to Jan. 5th, 2017. The enrollment criteria included[47]: (1) Ultrasound suspicious malignant 
thyroid nodules with indication for fine needle aspiration biopsy (FNAB); (2) Histology 
proved malignant thyroid nodules. All patients together with 3 volunteers underwent US 
examinations including both traditional US imaging and color Doppler flow imaging (CDFI). 




the blood flow patterns were obtained through US imaging and CDFI. After then, PA/US dual 
mode imaging was performed on the thyroid nodules. The patient enrollment and the imaging 
procedure were approved by the institutional ethics committee of PUMCH. Informed consent 
was signed by all patients before performing the PA/US imaging. 
4.4  Preclinical study results 
PA, US and CDFI imaging results from one normal and three cancerous cases are 
presented in this section. The CDFI and the PA/US dual mode imaging results of each case 
were compared. After presenting PA/US images, detailed information from all of the ten 
patients, including age, sex, depth and size of lesion, as well as the histological diagnosis 
results are provided[47] in Table4.1. 
Imaging results from a healthy right thyroid are shown in Fig4.2[47]. The middle panel is 
the pure US imaging result, while the left panel is the CDFI result and the right panel is the 
PAI result. Anatomical structures including skin, muscle, carotid, thyroid, trachea, and 
vertebrae were marked in Fig4.2 (b). Compared with sporadic blood flow signals in the thyroid 
region from CDFI results, PAI results reveal much more abundant PA signals, demonstrating 
that PAI is more sensitive to vessels in the thyroid parenchyma. However, the PA signals from 
the carotid artery could hardly be seen. This may be due to the strong absorption of the muscle 





Fig4.2 Imaging results from a healthy right thyroid. (a) CDFI result; (b) gray scale US B-
scan; and (c) PA/US imaging result. GP (gel pad), SK (skin), MU (muscle), CA (carotid), 
TH (thyroid), TR (trachea), VE (vertebrae).[47] 
Imaging results of three thyroid cancerous cases are shown next. Results from a left lobe 
papillary thyroid cancer (PTC) (case No.8 in Table4.1) is first shown in Fig4.3[47]. The thyroid 
nodule had the largest diameter of 9 mm with the center lying about 1.3 cm beneath the skin. 
Both of the intra-nodular and peripheral vessels are clearly revealed by either CDFI or PAI 
results. Additionally, from PAI results, we could see that there were two highly suspected 
feeding vessels locating near the upper boundary of the thyroid (white dashed arrows). The 
pathological results of this case show that the anterior capsular of the thyroid and the peripheral 
muscle was infiltrated by the tumor. From the results of H&E and immune histochemical 
evaluation, strong CD34 showed up in the thyroid anterior capsular area. These histological 
results demonstrate the existence of the vessels in the thyroid anterior capsular. Besides, VEGF 





Fig4.3 Imaging results from a left lobe papillary thyroid cancer (PTC, Follicular variation) 
with the largest diameter of 9 mm. (a) CDFI result; (b) gray scale US B-scan; and (c) PA/US 
imaging result. Solid white arrow indicates left lobe PTC, and dashed white arrows indicate 
suspected feeding vessels.[47] 
Imaging results from a right lobe PTC (case No.9 in Table4.1) are shown in Fig4.4[47]. 
The largest diameter of the nodule was 13 mm and the center of the lesion was around 1.5 cm 
beneath the skin. In CDFI results, strong vascular signals only showed up surrounding the 
lesion, while PA/US imaging results showed more abundant PA signals in other parts of the 
thyroid. Histological diagnosis demonstrates that invasion existed in thyroid capsular and 
peripheral tissues. 
 
Fig4.4 Imaging results from a right lobe PTC with the largest diameter of 13 mm. (a) CDFI 





Another left lobe PTC (case No.6 in Table4.1) with the largest diameter of only 3 mm is 
shown in Fig4.5. The center of the lesion was about 1.0 cm beneath the skin. PAI results 
(Fig4.5 (c)) showed plenty of PA signals in both the lesion region and the surrounding thyroid 
parenchyma, while CDFI results only showed few blood signals in the same regions. 
 
Fig4.5 Imaging results from a left lobe papillary thyroid cancer (PTC, Follicular variation) 
with the largest diameter of 3 mm. (a) CDFI result; (b) gray scale US B-scan; and (c) PA/US 
imaging result. White arrow indicates the left lobe PTC.[47] 
In the three cases presented above, PAI shows the capability to reveal both the peripheral 
and intra-nodular vessels of human thyroid. The following table presents detailed information 
of 10 cases with thyroid cancers. Three types of information are provided: 1) Basic information 
including sex and age of patients; 2) Lesion information including lesion size, and lesion depth; 
3) Imaging results including PAI results, CDFI results; 4) Histological results. 
Table4.1 The clinical information, comparison between PAI and CDFI, and histology results[47] 
Case 
No. 




PA vs CDFI Histological diagnosis 
1 
 
F 51 1.5 7 PAI showed more 
signals than 
CDFI  
Left lobe papillary thyroid 
micro-carcinoma (PTMC), 











Left lobe PTMC with 
follicular variation  
3 
 
F 52 1.8 5 Due to depth 
limitation, PAI 
only showed 
more signals in 
upper-half of the 
tumor than CDFI 
Left lobe PTMC 
4 
 




Left lobe PTMC 
5 
 




Right lobe PTMC 
6 
 




Left lobe PTMC 
7 
 




Left lobe PTC with large 
area of intra- tumor 
necrosis 
8  F 23 1.3 9 PAI showed more 
signals in tumor 
and anterior 
thyroid capsular  
Left lobe PTC, with 
invasion of anterior thyroid 
capsular and peripheral 
muscles. Ki67: 1%, 
VEGF+ 
CD34: ++ 
9  F 37 1.5 13 PAI showed more 
signals than 
CDFI 
Right lobe PTC, with 
invasion to thyroid capsular 





Ki67 2%, VEGF+ 
10 M 43 Left lobe: 
2.5 




Left and right lobe PTMC. 
Ki67 5%, VEGF+, 
Calectin-3+, CydinD1+, 
CD34++ 
   Right lobe: 
3.5 
7 CDFI showed 
more vascular 
information 
Based on the above table, PAI results from 7 out of 10 thyroid cancerous cases reveal 
more abundant vascular information than CDFI results either inside lesions or in thyroid 
capsular regions. Among three cases where PAI showed similar results with CDFI (case No. 
5, No.7, No. 10), the lesion in case No.10 was relatively deeper than other lesions (2.5 cm 
depth for left lobe and 3.5 cm depth for right lobe), and thus the local fluence was too low to 
generate PA signals with enough amplitudes. In case No. 7, from histological diagnosis we 
could see that there was a large area of intra-tumor necrosis, indicating that few vessels existed 
inside the lesion. As a result, only few PA signals showed up inside the lesion.  
4.5  Summary and discussion 
In this study, PA/US dual mode imaging was applied to evaluate thyroid nodules. From 
10 cases of thyroid cancers and 3 cases of healthy thyroids, we found that PAI is able to provide 
abundant vascular information. With the aid of US imaging, the vascular information provided 




in most cases, PAI could provide more vascular information than CDFI. This is mainly due to 
the difference existing in the mechanisms of two imaging modalities: CDFI utilizes Doppler 
effect and thus highly depends on the velocity and the direction of blood flow. In vessels where 
the blood flow velocity is very low, CDFI may not be able to reveal the correspondent vascular 
information. Different from CDFI, PAI depends on the existence of optical absorptive 
components such as hemoglobin, and thus is insensitive to the blood flow velocity. As a result, 
for small vessels where the blood flow is very slow, PAI is more sensitive than CDFI. 
There are also limitations in PAI. First of all, because PAI highly depends on the local 
fluence in the imaged region, if light attenuates too much before it arrives at the regions of 
interest, only few PA signals can be generated. For example, in Fig4.3-Fig4.5, we could clearly 
see that as the imaging depth increased, PA signals became weaker. Few signals from the 
carotid in Fig4.2 also suggests that if highly absorptive tissue exists above the regions of 
interest (muscle layer in this case), PAI will be affected. Second, since PA signals are 
essentially ultrasound waves, they can be reflected at tissue boundaries where the mismatch 
of acoustic impedances exists. For example, in trachea regions in Fig4.2 and Fig4.5, where 
optical absorptive components were not expected, PA signals also showed up. Third, a 
handheld US linear array has a limited reception angle. However, since thyroid nodules locate 





Our study demonstrates that the combination of PAI and US imaging has multiple 
advantages: First, PAI can provide important complementary information such as vascular 
information to US imaging. Second, because physicians are familiar with traditional US 
imaging, the imaging process is convenient especially when combined with a high-end clinical 
US system. The high-quality anatomical information provided by the high-end clinical US 
system can aid in interpreting PAI results more accurately. 
In the future, to add more diagnostic value, studies including both malignant and benign 
thyroid nodules should be carried out. Moreover, multi-spectral PAI can be investigated to 
perform functional analysis such as exploring the difference of SO2 between benign and 
malignant lesions. Additionally, 3D PAI can also be developed to reveal more comprehensive 





CHAPTER 5  3D PA/US FUNCTIONAL IMAGING OF BREAST 
CANCERS 
In this chapter, 3D PA/US functional imaging on breast cancer was investigated. The 
common imaging modalities for diagnosis of breast cancer are first reviewed. Next, the 3D 
PA/US functional imaging system updated from 2D PA/US imaging system described in 
Chapter 2 is introduced. With the updated 3D PA/US functional imaging system, we carried 
out the clinical study where 24 patients with either benign breast tumors or malignant breast 
tumors were enrolled. Quantitative analysis was performed on the SO2 values obtained from 
3D PAI results of 24 patients. We found that the SO2 values in both intra-tumor regions and 
peri-tumor regions of malignant cases were significantly higher than those of benign cases. 
These results demonstrate that 3D PA/US functional imaging has the potential in aiding 
diagnosis of breast cancer with a robust quantitative analysis. 
5.1  Background 
Among the female population worldwide, breast cancer is most common and accounts 
for around 14.6% of all new cancer cases in the United States in 2019[66]. It is important to 
detect breast cancer in the early stage (T1 stage) because it can lower mortality and burdens 
on society as a whole[67]. Two most widely used imaging modalities for detecting breast cancer 




is suitable for detecting lesions especially in dense breasts[69]. Mammography is superiorly 
sensitive to the microcalcifications[70] but is radioactive and not suitable for dense breasts. 
Both of the US detection and X-ray screening are playing important roles in diagnosis of breast 
cancers, however, to further improve the diagnosis accuracy of breast cancer especially the 
diagnosis accuracy of early stage ones is still desired because it can reduce the unnecessary 
biopsy of benign lesions[71].  
During the past decade, PAI of breast cancer has gained lots of interest for the following 
reasons: 1) PAI utilizes optical contrast in imaged tissue and thus can reveal complementary 
biological information for other imaging modalities; 2) PAI is highly sensitive to vessels due 
to the strong optical absorption of the intra-vascular hemoglobin[7,72,73]. Microvascular 
information is of vital importance because it is highly related to tumor angiogenesis and 
metastasis [74,75]; 3) When employing multispectral PAI, functional information such as SO2 
can be obtained, providing essential information for evaluating metabolism levels of lesions 
as well as therapeutic response. Owing to these unique advantages, PAI has made significant 
progresses in clinical studies of breast cancer[29,39,76-78]. 
Among all the PAI systems developed for breast cancer imaging, the combination of PAI 
with handheld US systems has attracted lots of interest especially in clinical studies[14,29,79,80]. 
The integration has the advantage of operational convenience because the operators are 




traditional US imaging results, vascular structure in PAI can be well located with anatomical 
structure obtained in US imaging. Due to the above advantages, integrating PAI with handheld 
US has achieved many progresses in diagnosis of breast cancer[11,29]. One of the most 
prominent studies was a multi-central study reported in 2018[11]. In this study, 2105 subjects 
were enrolled for multispectral PA/US imaging. The results demonstrate that PA/US can 
increase the specificity in diagnosis of breast cancer compared with pure US[11]. In another 
study enrolling 7 breast cancerous patients and 6 healthy volunteers, optically absorptive 
components including oxy-hemoglobin (Hb), deoxy-hemoglobin (deHb), total hemoglobin 
(tHb) were resolved[29]. The comparison between breast cancerous cases and healthy breast 
cases reveals that Hb, deHb and tHb are more abundant in invasive carcinoma than in 
unaffected breast tissue and peritumoral tissue. 
Most of the above pioneer clinical studies relied on 2D PA/US imaging. However, with 
2D imaging, important values from other cross-sections of lesions may be missed. Instead, 
with the aid of 3D imaging, more comprehensive information of tumor can be obtained. 
Specifically, when combining 3D US imaging with 3D functional PAI, volumetric functional 
information such as volumetric mean SO2 value can be calculated. Moreover, with the aid of 
3D US imaging, intra-tumor regions and peri-tumor regions can be analyzed separately, which 
may potentially improve the diagnosis accuracy of breast cancer[81]. Additionally, with the 




reduced and direct quantitative analysis can be applied without having to select 2D B-scan 
slices. Furthermore, 3D morphological distribution of vessels can contribute to a more 
comprehensive assessment of blood supply in and surrounding lesions. Although the 
feasibility of 3D PA/US imaging has been verified by either scanning a linear probe or by 
utilizing a 2D array [82-84], few of them has been applied to breast imaging.  
In this study, we developed a 3D PA/US functional imaging system, which was updated 
from the 2D PA/US imaging system described in Chapter 2. With the 3D PA/US functional 
imaging system, we performed 3D PA/US functional imaging on patients with either benign 
breast tumors or malignant breast tumors. The main purpose of this study is to explore the 
potential value of quantitative analysis with 3D PA/US functional imaging in achieving a 
higher diagnosis accuracy of early breast cancer. 
5.2  3D PA/US functional imaging system 
The dual-mode imaging system in this study was based on a high-end clinical US 
machine (Resona 7, Mindray Bio-Medical Electronics Co., Ltd., China)[47] , which had the 
ability to perform parallel data acquisition required by PAI as introduced in Chapter 2. PA 
images were reconstructed in real time with the delay and sum algorithm. The linear probe 
(L9-3U, Mindray Bio-Medical Electronics Co., Ltd., China) with 192 elements and a center 




multispectral PAI, an OPO tunable laser (Spitlight 600-OPO, Innolas laser GmbH) which 
could generate 700-850 nm laser pulses at 10 Hz was integrated with the US system. In our 
study, 750 nm and 830 nm were used for PA functional imaging. 750 nm and 830 nm were 
chosen because deHb has stronger absorption at 750 nm and Hb has stronger absorption at 830 
nm[85] (see Fig5.2). The higher difference in absorption between deHb and Hb would be 
beneficial for SO2 calculation. Additionally, the power of the OPO laser is spectrally varied as 
shown in Fig5.2. At 750 nm and 830 nm, the pulse energy is still high enough to achieve good 
signal to noise ratio (SNR). 
 





Fig5.2 Energy-wavelength curve of the OPO laser. 
To achieve PA/US real time imaging at two wavelengths, a time division multiplexing 
approach was employed. SO2 map was represented together with PA images at two 
wavelengths at 5 Hz frame rate. The photographs of the imaging system and the 3D scanning 
device are presented in Fig5.3 (a) and Fig5.3 (b) respectively. 
 




The 3D scanning device fixed on the 3D scanning arm included a probe holder and an 
electric motor (Fig5.3 (a)). By scanning the probe across the breast skin surface, a local 3D 
PA/US functional imaging can be performed. The electric motor moved at a steady velocity 
(1mm/s) during 3D imaging, while a set of 2D US and PA images at 750 nm and 830 nm were 
acquired at 0.2 mm step intervals simultaneously (see Fig5.4).  
 
Fig5.4 Design of 3D imaging device in SOLIDWORKS. 
The total scanning length was 4 cm and the total scanning time was 40 seconds. After the 





Fig5.5 (a) Schematic diagram of 3D scanning device. (b) 3D rendering of vascular 
networks co-registered with the tumor surface.[86] 
To render 3D PA/US images (Fig5.3 (b)), we first imported a set of 2D SO2 maps into 
Amira (version 6.0, Visage Imaging) to obtain the 3D SO2 map. Next, we extracted SO2 values 
larger than 40% and less than 100% from the 3D SO2 map to obtain vascular networks. A 
threshold of 40% was set because according to previous studies, SO2 values in breast tumors 
normally do not go below 40%[78,87,88]. Besides, due to the fact that the patients with malignant 
breast tumors enrolled in this study were all at T1 stage (see Section 5.4), abnormal SO2 values 
caused by necrosis would not present in this study. To render tumor regions together with 3D 
vascular networks, the surfaces of the tumor regions were first marked manually based on US 





5.3  Quantification analysis strategy 
The dominant endogenous photo absorbers in the near-infrared range are Hb and deHb[8]. 
At location 𝒓, PA signals at optical wavelength 𝜆𝑖 can be described as Eq. (5.1)
[89]. In this 
equation, Γ is the Grüneisen parameter of the tissue. 𝐹(𝜆𝑖, 𝒓) is the optical fluence at optical 
wavelength 𝜆𝑖 . 𝐶(𝐻𝑏, 𝒓)  and 𝐶(𝑑𝑒𝐻𝑏, 𝒓)  are the concentrations of Hb and deHb, 
respectively. 𝐻𝑏(𝜆𝑖) , 𝑑𝑒𝐻𝑏(𝜆𝑖) are the known molar extinction coefficients of Hb and 
deHb at wavelength 𝜆𝑖. 
 𝑃𝐴(𝜆𝑖, 𝒓) = Γ𝐹(𝜆𝑖, 𝒓)(𝐶(𝐻𝑏, 𝒓) 𝐻𝑏(𝜆𝑖) + 𝐶(𝑑𝑒𝐻𝑏, 𝑟) 𝑑𝑒𝐻𝑏(𝜆𝑖)) (5.1) 
Due to the fact that at 750 nm and 830 nm, both of the absorption coefficient 𝜇𝑎(𝜆) and 
the reduced scattering coefficient 𝜇𝑠
′ (𝜆) of the background breast tissue are similar[90,91], the 
optical fluence 𝐹(𝜆750𝑛𝑚, 𝒓) and 𝐹(𝜆830𝑛𝑚, 𝒓) were assumed to be approximately same 
after normalization with the real-time recorded illumination power of laser pulses at each 
wavelength. Given the definition of SO2 as follows, 
 𝑆𝑂2(𝒓) = 𝐶(𝐻𝑏, 𝒓)/(𝐶(𝐻𝑏, 𝒓) + 𝐶(𝑑𝑒𝐻𝑏, 𝒓)) (5.2) 
the SO2
 at each pixel can be derived from PA values at 750 nm and 830 nm, as shown in Eq. 







𝑃𝐴(𝜆750𝑛𝑚,𝒓)( 𝑑𝑒𝐻𝑏(𝜆830𝑛𝑚)− 𝐻𝑏(𝜆830𝑛𝑚))+𝑃𝐴(𝜆830𝑛𝑚,𝒓)( 𝐻𝑏(𝜆750𝑛𝑚)− 𝑑𝑒𝐻𝑏(𝜆750𝑛𝑚))
 (5.3) 
To analyze intra-tumor regions and peri-tumor regions separately, tumor contours in 2D 
US slices were first marked manually by experienced physicians. 3D tumor boundaries were 
then obtained from a set of 2D US slices. To automatically extract peri-tumor regions, we 
proposed a method based on automatically calculating the least volume ellipse (LVE) 
enclosing the 3D tumor regions in MATLAB (MathWorks, Inc.)[93]. Similar methods have 
been verified in semi-automatically estimating tumor volumes in CT[94]. Due to the uniqueness 
of LVE enclosing the 3D tumor regions, the analysis process is robust and repeatable. After 
obtaining the LVE, the extensional ellipse was calculated by extending each length of three 
axes of the original LVE by 1.2 times. We defined regions inside the extensional ellipse and 
outside the tumor regions as the tumor surrounding regions (Fig5.6). After obtaining the intra-
tumor region and the tumor surrounding region of each tumor, volumetric mean SO2
 in each 
region was calculated through dividing the sum of SO2 values within the range of 40% and 
100% by the pixel numbers where SO2 values were within the same range. Similarly, we also 





Fig5.6 Representation for definitions of tumor and tumor surrounding regions.[86] 
5.4  Patients enrollment and imaging procedure 
Patients with breast tumors were consecutively recruited from the outpatients and 
inpatients of breast surgery department at Peking Union Medical College Hospital (PUMCH) 
in from November 2017 to January 2018. The enrollment criteria included: 1) the maximum 
diameter of the lesion was smaller than 2 cm; 2) the patients received a BIRADS rating from 
3 to 5 with indication for surgery or biopsy; 3) tumor boundaries were clear in US imaging. 
Our study protocol was approved by the institutional ethics committee of Peking Union 
Medical College Hospital. Written informed consent was obtained from all participants. 
Imaging examinations via US and/or X-ray mammography, MRI by experienced 
radiologists were first performed on all patients. After the conventional US imaging was 
performed, 2D and 3D PA/US dual mode imaging were performed. It should be noted that 
patients with BIRADS 3 were all found to have an increasing size of tumor in follow-up visits 




summarized as Fig5.7 shown. 
In total, 16 patients with T1 stage invasive breast cancers (IBCs) and 8 patients with either 
breast fibroma or breast adenosis were included in the following analysis. In addition to 16 T1 
stage IBCs and 8 benign lesions of these 24 patients, PAI results of 22 contralateral healthy 
breasts were also analyzed, with 14 of them from patients with T1 stage IBCs, and 8 of them 
from patients with benign lesions. Two contralateral breasts were excluded due to the existence 
of lesions inside. 
 
Fig5.7 Flow chart of the imaging procedure 
5.5  Statistical analysis 




results were grouped into three categories: benign group (either fibromas or breast adenosis, 
n=8), malignant group (T1 stage IBCs, n=16) and normal group (contralateral healthy breasts, 
n=22). 
Because tumor size is also closely related to the malignancy of lesions, to reduce 
cofounding effects of tumor sizes, subgroup analyses were carried out. In each subgroup, only 
tumors with similar size were included. For example, 5 IBCs and 5 benign tumors with largest 
diameters ranging from 1 to 1.5 cm were included in one subgroup. For tumors with largest 
diameters between 1.6 cm and 2.0 cm, due to the mismatch in sample size between IBCs (10) 
and benign tumors (2), 2 out of 10 IBCs were randomly selected to form a subgroup with the 
two benign tumors. In total, there were 45 combinations to make sure each of 10 IBCs were 
selected at least once. Hence, we performed subgroup analyses 45 times for the size group 
where largest diameters of tumors were between 1.6 cm and 2.0 cm. Detailed information of 
tumor sizes and correspondent sample sizes in each subgroup was summarized in Table5.1. 
Nonparametric two tails Mann-Whitney U-test was used to calculate the statistical 
significance between either two groups among benign, malignant and healthy groups. This 
statistical method was chosen because our sample size to small to meet the normal distribution 
requirement from traditional t-test statistical method. A P value of 0.05 was considered to 
indicate 95% statistical significance. We used the Hodges-Lehmann estimator to calculate the 




performed with MATLAB (MathWorks, Inc.). 
Table5.1 Tumor size and correspondent sample size[86] 
Size(cm) Sample size of T1 stage IBCs Sample size of benign tumors 
[0.5, 0.9] 1 1 
[1, 1.5] 5 5 
[1.6, 2] 2(out of 10) 2 
5.6  Results 
5.6.1  Statistical results 
Statistical results of the volumetric mean SO2 from 3 groups (16 T1 stage IBCs, 8 benign 
lesions and 22 contralateral healthy breasts) were shown in Fig5.8. 
 
Fig5.8  (a) Box plots of volumetric mean SO2 values of the benign, normal and malignant 
groups in tumor regions. (b) Box plots of volumetric mean SO2 values of the benign, normal, 
malignant groups in tumor surrounding regions.[86] 




malignant group was 7.7% lower (95% confidence interval: 2.1%, 12.4%) than that of the 
benign group (P=0.016) and was 3.9% lower (95% confidential interval: 2.2%, 5.5%) than 
that of the normal group (P=0.010). In peri-tumor regions (Fig5.8(b)), the SO2 volumetric 
mean values of the malignant group was 4.9% lower (95% confidence interval: 1.6%, 8.4%) 
than that of the benign group (P=0.009). Differences of SO2 volumetric mean values between 
other groups such as the benign group and the normal group were not significant at the 95% 
level.  
In the analyses of 47 subgroups with the control of tumor sizes, SO2 volumetric mean 
values in both tumor regions and peri-tumor regions were found to be significantly lower in 
malignant tumors than in benign tumors. In tumor regions, the SO2 volumetric mean value of 
the malignant group was at least 7.0% lower (95% confidence interval: 1.4%, 14.0%) than that 
of the benign group (0.005≤P≤0.028). In tumor surrounding regions, the SO2 volumetric 
mean value of the malignant group was at least 4.0% lower (95% confidence interval: 0.5%, 
9.3%) than that of the benign group (0.010≤P≤0.028).  
By varying the SO2 threshold both inside tumors (Fig5.9(a)) and in tumor surrounding 
regions (Fig5.9(b)), we obtained receiver operating characteristic (ROC) curves for 






Fig5.9 ROC for differentiating malignant tumors from benign tumors by varying the SO2 
threshold in both (a) tumor regions and (b) tumor surrounding regions.[86] 
With a cut off value of 78.2% for SO2 value inside tumors, a sensitivity of 100%, a 
specificity of 62.5% were obtained. The area under the ROC curve (AUC) was 0.81. With a 
cut off value of 77.9% for SO2 value in tumor surrounding regions, a sensitivity of 100%, a 
specificity of 75% and an AUC of 0.84 were obtained.  
Similarly, for all 47 subgroup analyses with the control of tumor size, with a cut off value 
of 78.2% for SO2 value inside tumors, an average sensitivity of 100%, an average specificity 
of 62.5% and an average AUC of 0.86 were achieved. With a cut off value of 77.9% for SO2 
value in tumor surrounding regions, an average sensitivity of 100%, an average specificity of 
62.5% and an average AUC of 0.85 were achieved. These results show that the physiological 




and thus to provide important complementary information to traditional US imaging. 
We also performed statistical analysis on vasculature density in peri-tumor regions and 
intra-tumor regions because we did see a trend during the clinical study that the vessel density 
in malignant cases were higher than benign cases. Statistical results are shown as below: 
 
Fig5.10 Vascular density in tumor regions and tumor surrounding regions 
From statistical result, we could see that although there is a trend that the malignant group 
has a higher vascular density than the benign group, there is no significant difference between 
two groups at 95% significant level. One potential reason is that the probe we used did not 
have a high sensitivity, which is extremely important for PAI because PA signals in deep tissue 
can be much weaker than traditional US signals. Another reason is that the sample size in our 




In addition, we found that the variance of malignant group was much higher than the 
benign group. This result suggests that the physiological information of malignant tumors may 
vary a lot from case to case. 
5.6.2  PA/US imaging results 
Representative imaging results of invasive breast cancers and benign breast lesions are 
shown in this section. The SO2/US fused imaging results of a malignant tumor (IBC) and a 
benign tumor (fibroadenoma) are shown in Fig5.11 (a) and Fig5.11 (b), respectively. In the 
imaging result of the malignant tumor (Fig5.11 (a)), more abundant vasculatures and lower 
SO2 values showed up in and surrounding tumor regions, while only a few vasculatures and 
relatively higher SO2 values were revealed in the benign lesions (Fig5.11(b)). Based on the 
pure US imaging results, it was difficult to confidently grade the malignant tumor because it 
had a clear margin and a regular shape, which are typical characteristics of benign tumors.  
 





In addition to 2D SO2/US imaging results, X-ray mammography and CD31 
immunochemistry (IHC) vascular staining results of the same cases are shown in Fig5.12. The 
malignant tumor could hardly be detected from X-ray results (Fig5.12 (a)) because neither 
obvious calcification nor clear margins showed up. From the X-ray results of the benign tumor 
(Fig5.12 (b)), it was also difficult to identify the lesion. Consistent with the 2D PA/US imaging 
results, more CD31 vascular staining showed up in and surrounding the malignant tumor 
(Fig5.12 (c)) than the benign one (Fig5.12 (d)) according to IHC vascular staining results. 
 
Fig5.12 X-ray mammography results of the same (a) invasive breast cancer and (d) breast 
fibroadenoma as in Fig5.11. CD31 immunochemistry (IHC) vascular staining results of the 
same (c) invasive breast cancer and (d) breast fibroadenoma as in Fig5.11. Both the tumor 




The 3D vascular networks of the same tumors shown above are presented in Fig5.13 (a, 
b). Similar with 2D imaging results, more abundant vasculatures showed up around the 
malignant tumor, whereas much less vasculatures showed up around the benign tumor. We 
also plotted the probability density distribution of SO2 values in tumor regions and in tumor 
surrounding regions (see Fig5.13 (c, d)). The SO2 distributions both inside and around the 
malignant tumor showed a lower trend than those of the benign tumor. 
 
Fig5.13 3D vascular networks of the same (a) invasive breast cancer and (d) breast 
fibroadenoma as Fig5.11 showed. Probability density distributions of SO2 values in the (c) 




5.7  Summary and discussion 
In this pilot clinical study, we performed 3D PA/US functional imaging on patients with 
small breast tumors (less than 2cm). From imaging results, we found that conventional US 
imaging could clearly display the edge of breast tumors, even for some lesions that were not 
easy to detect with X-Ray, as shown in Fig5.12(b). Besides, from 3D vasculature map shown 
in the benign case and the malignant case, we could see a trend that the vasculature was more 
abundant in the malignant case than the benign case. The reconstruction of 3D vasculature 
map could provide an intuitive assessment of the vasculature distribution of the benign case 
and the malignant case.  
Because in this study, we mainly focused on what value could quantification of PAI on 
breast cancer could provide, we did not perform a statistical analysis for 2D PAI results, 
although we did acquire them right before 3D PAI. 
From statistical results, we found that invasive breast cancers had obviously lower 
volumetric mean SO2 than the benign group or the healthy group. With the SO2 cut-off values 
described in Section 5.6.1, the sensitivity and specificity in differentiating T1 IBC from benign 
tumors were favorable.  
Although we had performed an analysis for vasculature density in intra-tumor regions 




the benign group even though we did see a trend in two cases shown with results of 2D imaging 
and 3D vasculature information. We also found that, in the malignant group, the variance of 
vasculature density is much larger than that of the benign group. This observation suggests the 
complexity of using one physiological index to evaluate malignant cases. Although the future 
increase of the sample size may provide a much more concrete conclusion. 
Based on the above statistical analysis, we could see that with PAI added to US imaging, 
more functional information, such as SO2 distributions of tumors could potentially enhance 
the diagnostic confidence. However, the difference of SO2
 between the malignant group and 
the benign group we found was still not high enough to provide a very promising diagnosis 
accuracy. In the future, the combination of SO2 with patterns of PA signals may have provide 
a more comprehensive information. Identifying patterns of PA signals will require the machine 
learning algorithms including patterns recognition. And similarly, increasing the sample size 
may also aid in identifying a much more confident SO2 values. 
We also compared our results with several previous studies. For the imaging ability of 
PA/US dual mode imaging system, our self-developed system was very similar to the PA/US 
dual mode imaging system made by Seno Medical Instruments Inc [11]. For the US imaging, 
because our method was based on a high-end clinical imaging system, the imaging quality of 
US imaging is very beneficial for physicians to perform US imaging and identify lesions with 




was developed mainly for PA imaging instead of US imaging, the imaging quality of US 
imaging may not be good enough for clinical physicians to identify a clear margin of the 
lesions. Besides, although we did not show CDFI results in this Chapter, we did have the 
imaging ability for CDFI, as shown in the clinical study of thyroid cancer. The additional 
information provided by CDFI may also provide more comprehensive information for 
diagnosis of diseases. For functional PAI, the imaging system provided by Seno Medical could 
present the hemoglobin concentration map and hemoglobin concentration map, while our 
system can directly provide the information of oxygenation saturation. Both of these two 
presenting methods have their unique advantages. For the system by Seno Medical, the 
imaging results were optimal for separating analysis of oxygenated hemoglobin and 
deoxygenated hemoglobin more intuitively. While our method provided a more intuitive way 
for evaluation of oxygenation saturation. 
Additionally, our system was able to perform 3D imaging to provide a more 
comprehensive information, while their system could only perform 2D imaging. From the 
statistical assessment, physicians would score breast lesions just as they do in US imaging. 
This makes the performing PAI more operator-dependent, and thus may decrease the 
robustness of imaging explanation. While with 3D imaging, quantification analysis can be 
obtained directly with few operator-dependence. This would also benefit the advancement of 




decrease the cost-effectiveness of PAI because it will request lots of training efforts for 
physicians to be familiar with the whole imaging procedure. 
We also compared our results with previous research. We found that our results are in 
agreement with a previously reported clinical study in which 2D PA/US functional imaging 
were performed on more than 2000 breast tumors[11] with the PA/US system developed by . 
Their results found that SO2 had a lower trend in malignant tumors than in benign ones. In 
another clinical study based on photoacoustic mammography, SO2 values in the malignant 
tumors were found lower than in the normal breasts[78], which was consistent with our results. 
The potential reasons for hypoxia in malignant tumors have been widely explored [95-97]. 
One predominant causative factor is severe structural and functional abnormalities in the 
tumor microcirculation. These abnormalities include dilations, and elongated or tortuous 
vascular networks. In addition to the significant difference of SO2 values inside tumors, we 
also found a significant difference of SO2 values in tumor surrounding regions. The 
mechanism behind this observation is not clear yet. Based on previous studies of breast 
contrast enhanced imaging, peripheral enhancement regions of breast tumors were found to be 
closely related to the malignity[98,99]. 
Compared to 2D functional PA/US imaging[11,29], 3D functional PA/US imaging can be 




evaluation of the overall features of tumors. For instance, Fig5.14 displays the average SO2 
values in different 2D slices within the tumor region of a malignant case. We could see that 
the SO2 values varied largely from slice to slice, and as a result, it is hard to select an 
appropriate 2D slice for evaluation of the tumor.  
 
Fig5.14 Average SO2 variation curve within different slices of a malignant tumor
[86] 
Second, compared to the PA scoring system dependent on manually scoring as in US 
imaging[11], quantification analysis with 3D PAI can avoid intra-observer difference and thus 
deliver a diagnostic index with better repeatability and reliability. Third, with 3D PA/US 
imaging, more comprehensive information including 3D distributions of vessel networks can 
be achieved. 




angle of the straight linear probe, many of the reconstructed vessels tended to be parallel with 
the scanning direction. However, our study implies that even based on the “biased” 
reconstructed results, a valuable quantitative evaluation is still achievable. Besides, due to the 
difficulty in obtaining an accurate optical fluence map, calculation of hemoglobin 
concentration is not available yet. For further improvement, utilizing multiple wavelengths to 
assess the optical properties of background tissue may be available. With more confident 
optical properties, the diagnosis value of SO2 can also be increased. Besides, it would also be 
possible to assess the accuracy of SO2 when performing multi-wavelength PAI and get the 
optical spectrum of the regions where SO2 values are calculated. If the measured spectrum is 
too different from the SO2 values spectra based on spectra information of oxygenated-
hemoglobin and deoxygenated-hemoglobin, then it is reasonable to suspect that the 
measurement of the SO2
 values is not accurate enough. 
Finally, although our analysis demonstrates promising results that 3D PA/US functional 
imaging could potentially aid in diagnosis of breast tumors, an increase of overall sample size 
is necessary in the future for verifying a more accurate SO2 cut-off value, which may further 





CHAPTER 6  A COMPARISON BETWEEN SURFACE ACOUSTIC 
WAVES INDUCED BY LASER AND BY ARF 
In this chapter, two generation mechanisms of surface acoustic waves (SAWs) are 
explored. The two generation mechanisms are optical excitation and acoustic radiation force 
(ARF) excitation, respectively. To track the propagation of SAWs, ultrafast ultrasound (US) 
imaging was employed. ARF-induced SAWs and laser-induced SAWs were first compared 
with a tissue-like phantom. Next, the frequency contents of SAWs generated by ARF and 
pulsed laser light were compared with the same excitation duration and different SAW 
bandwidths were observed. At last, the generation and the propagation of excited waves with 
the excitation regions below the surface were compared. Additionally, the relationship 
between shear wave amplitude and optical fluence were also investigated. The study presented 
in this chapter can potentially extend the applications of laser-induced SAWs in biomedical 
fields. 
6.1  Background 
Initially, generation of SAWs utilizing a pulsed laser beam was introduced to investigate 
mechanical properties of plates and thin metal films[100-102]. Typically, a laser pulse can be used 
to generate SAWs on the surface of the material and the subtle displacement at surface can 




interferometers[102,103]. Applications of laser-induced SAWs have also been presented in 
studies of biological tissues[104-106]. For instance, several studies have shown that laser-induced 
SAWs can be utilized to investigate the stiffness of corneal ectasia[107-109]. In these studies, 
optical coherence tomography (OCT) was used for detection of the displacement induced by 
laser pulse on the corneal surface. The results demonstrate that imaging of laser-induced SAWs 
has the ability of measuring the stiffness of superficial tissue. 
An alternative way to induce SAWs in soft tissues is to apply ARF with focused 
ultrasound beams at low frequencies[110-112]. In addition to imaging SAWs by OCT, ultrafast 
US imaging can also be employed with the same transducer used for generating ARF beams. 
The imaging depth of OCT is around 2 mm while the imaging depth of ultrafast US imaging 
can reach several centimeters. By transmission of plane or diverging waves, ultrafast US 
imaging is able to attain a frame rate higher than 1000 frames per second, which is high enough 
for capturing surface acoustic waves with velocities of several meters per seconds in typical 
soft tissues.  
Laser-induced SAWs and ARF-induced SAWs have different characteristics. First, the 
generation mechanisms are different. With ARF excitation, SAWs are excited mainly due to a 
transfer of momentum from the propagating acoustic waves to the medium through attenuation 
or reflection of the ultrasonic wave[113]. Different from ARF excitation, generation of SAWs 




chapter, we first investigated the differences of SAWs induced by ARF and SAWs induced by 
pulsed laser light in terms of propagation velocities and frequency components, respectively. 
Next, we explored the difference in wave generation between ARF excitation and laser light 
excitation when excitation regions were underneath the surface. Finally, we analyzed the 
relationship between the optical fluence and the shear wave amplitude. For both laser-induced 
SAWs and ARF-induced SAWs, ultrafast US imaging was employed for measurements of the 
propagation of SAWs. 
6.2  Materials and methods 
Three experiments were conducted in total with the aim of comparing two mechanisms 
from the following three perspectives: propagation velocity, frequency component, and wave 
generation when excitation regions were below the surface [115]. 
In the first experiment, the propagation velocities of SAWs generated in phantoms with 
different stiffnesses were compared. We prepared three phantoms with different stiffnesses by 
dissolving gelatin powder in distilled water with different concentrations: 6%, 9%, and 12% 
w/v. To provide optical absorption, we added 0.5% (w/v) graphite powder to solutions. 
Additionally, two percent (w/v) 60-120 μm silica particles were added to provide US scattering. 
The dimensions of each phantom were same: 6.2 cm × 5.1 cm × 5.1 cm (L × W × H). 




imaging platform which was developed previously[116]. This platform was implemented on a 
programable US system (Vantage 256; Verasonics, Inc.). Laser pulse at 1064 nm wavelength 
with a pulse duration of 5 ns was provided by an Nd: YAG laser (Vibrant 532 I; Opotek Inc.). 
The laser was integrated with the imaging platform for the excitation of PA signals and 
photothermal SAWs. An optical fiber with a diameter of 1.5 mm was placed above the 
phantom for delivery of light. To acquire PA and US signals as well as provide the ARF push 
beam, a linear US transducer (CL 15-7; Philips Healthcare.) was employed. For acoustic 
coupling, we filled water between the transducer and the phantom surface. The system setup 
for the first experiment was shown below: 
 
Fig6.1 The system setup for the first experiment, where the imaging target was a rubber 




During the first experiment, we first performed PAI, and then ultrafast US imaging to 
track the laser-induced SAWs within and on the surface of the phantom. Particularly, we used 
the same laser pulse for generation of PA signals and for inducing subtle displacements, both 
of which were caused by photothermal effect. The propagation of SAWs was tracked by 
ultrafast US imaging starting 300 μs after the laser excitation. A total of thirty US images were 
captured at a frame rate of 3.3 kHz. After then, a 300 μs ARF pulse was emitted from the 
transducer to excite SAWs in the phantom. Another set of thirty ultrafast US images were 
acquired at the same frame rate right after the ARF push beam. To compare with laser-induced 
displacements, which mainly occurred at or near the phantom surface, ARF beam was also 
focused near the phantom surface (2 mm below the phantom surface).  
After obtaining the ultrafast US imaging results, we calculated the SAW velocity for both 
mechanisms. First, displacement maps were obtained by correlating adjacent ultrafast US 
images along the axial direction. For calculation of SAW propagation velocities, we selected 
two points 0.2 mm below the phantom surface. The horizontal locations of these two points 
were set to be 3.57 and 4.43 mm away from the excitation region, resulting the distance 
between these two points being 0.86 mm. The rationale for choosing these two location was 
as follows: 1) To make sure that these two locations were away from the excitation region so 
that artifacts caused by laser or ARF pulse can be avoided; 2) To make sure that these two 




signal-to-noise ratio (SNR). We then obtained the time-displacement curves at these two 
locations from displacement maps at different time points. The time delay of the SAWs 
propagating from one location to another was calculated with a correlation-based approach 
after interpolation with a time interval of 3 μs. Next, through dividing the distance between 
two points (0.86 mm) by the calculated time delay, we obtained SAW velocities.  
SAWs generated here were essentially Scholte waves because the interface between water 
and phantom was fluid-solid interface. Based on previous research, the velocity of Scholte 
waves is 84% of the shear wave speed[117], thus we multiplied a factor of 1.19 to calculate the 
shear wave speed. We performed the laser/ARF SAW imaging on each phantom four times. 
To calculate the statistical significance in shear wave velocity (SWV) values, we applied a 
two-sided student t-test with MATLAB (MathWorks, Inc.) for both the laser-induced SAW 
imaging and the ARF-induced SAW imaging.  
Next, in the second experiment, the spectra of ARF-based SAWs and laser-induced SAWs 
were compared. In this experiment, we made a phantom out of synthetic gel (Gelatin #5, 
Humimic Medical.). As in the first experiment, we added graphite powder with 0.5% (w/v) 
concentration for optical absorption. We also added 60-120 μm silica particles with a 
concentration of 2% (w/v) for ultrasound scattering. To match the ARF pulse duration and the 
optical excitation duration, another laser system (Quanta Ray; Spectra-Physics, U.S.) which 




300 μm diameter fiber on the edge of the transducer. At the phantom surface, the full width at 
half maximum (FWHM) of the laser beam was measured to be 400 μm. The optical fluence 
was 3.9 mJ/mm2, well below the ANSI limit 5.5 mJ/mm2 for the 100 μs laser pulse at 1064 
nm[48].  
We excited SAWs at the same location on phantom surface with the 100 μs ARF pulse 
and the 100 μs laser pulse separately. Ultrafast US imaging was performed immediately after 
the excitation pulse. The imaging frame rate was 3.3 kHz. As in the first experiment, we chose 
two locations for spectrum analysis. These two locations were 2.5 and 3.3 mm laterally away 
from the excitation region to allow attenuation of artifacts generated from the excitation center 
during excitation, and to maintain adequate SNR in measurements of displacement. We 
calculated displacement-time curves for these two regions after achieving the ultrafast US 
imaging results, and performed fast Fourier transform on them. 
In the third experiment, the difference in SAW phenomenon with excitation location 
below the surface was investigated. As in the first two experiments, the phantom used was 
made out synthetic gel with dimensions of 4.9 cm × 4.9 cm × 3.7 cm (L × W × H). 2% (w/v) 
60-120 μm silica particles were added to provide US scattering. Instead of adding gelatin 
powder for optical absorption, we placed a metal needle with 0.8 mm diameter 3.3 mm below 
the phantom surface. As a result, the excitation region was also 3.3 mm below the phantom 




generally highly absorbing[118]. The system setup is as following: 
 
Fig6.2 System setup for the third experiment 
We employed the same imaging system and the same laser system in the third experiment 
as in the first experiment. Fourteen ultrafast US images at a frame rate of 2.78 kHz were 
acquired 60 μs after the laser pulse. Next, we applied a 60 μs ARF pulse to the phantom. The 
US beam was focused 1.3 mm above the medal needle. Another set of fourteen ultrafast US 
images at a frame rate of 2.78 kHz were acquired right after the ARF pulse. In addition to 
investigate the difference in SAW phenomenon, we also explored the relationship between the 
optical fluence and the displacement amplitude. We applied three different optical fluences 




times for each fluence. The maximum amplitude of displacement was calculated 0.78 ms after 
the laser excitation in a region 3.3 mm below the phantom surface, same depth as the 
photoabsorber. Because SAW propagated in two opposite directions after excitation, there was 
a local maximum of displacement amplitude on both the left side and the right side of the 
photoabsorber. As a result, six measurements were carried out for each laser fluence in total. 
Detailed information of the system was listed in the following table. 
Table6.1  Detailed information of the imaging system 
US system Model Vantage 256, Verasonics 
Transducer 





Model Vibrant 532 I, Opotek Inc. 
Wavelength 1064 nm 
PRF 10 Hz 
Energy 40mJ/cm2~100mJ/cm2 
Pulse duration 5 ns 
Ultrafast US 
imaging 
Frame rate 2.78 kHz~3.3 kHz 




6.3  Results 
The co-registered PA/US imaging result of the 9% gelatin phantom in the first experiment 
was shown in Fig6.3[115]. PA signals in color scale demonstrated the location of laser excitation 
as well as the origin of photothermal expansion that induced following SAWs. 
 
Fig6.3 Combined US (grayscale map) and PA image of the tissue-mimicking gelatin 
phantom.[115] 
From Fig6.4, we could clearly see the propagation of laser-induced and ARF-induced 
SAWs in the displacement maps calculated from ultrafast US imaging results.  
 
Fig6.4 Displacement maps at four different time points obtained using ultrafast US imaging 
for (a) laser induced SAWs and (b) ARF-based SAWs.[115] 
SAW displacement was calculated at 1.5, 2.1, 2.7, and 3.3 ms after the laser/ARF 




were spatially matched. However, several differences also existed. First of all, the 
displacement at the excitation point was directed oppositely in laser-induced and ARF-induced 
SAWs. With laser excitation, the displacement at the excitation point was directed towards the 
imaging transducer while with ARF excitation, the displacement at the excitation point was 
directed away from the imaging transducer. The difference in the polarity of laser-induced 
SAWs and ARF-induced SAWs was due to the difference in the generation mechanisms. With 
ARF excitation, the initial displacement was caused by the push beam generated by the 
transducer, while with laser excitation, the initial displacement was caused by the 
photothermal expansion of the excited region. Secondly, the displacement amplitudes of laser-
induced SAWs were much less than the displacement amplitudes of ARF-induced SAWs, with 
the former of which being on the order of tens of nanometers while the latter of which being 
several micrometers. 






Fig6.5 SWV measurements (n=4) in gelatin phantoms of different gelatin concentrations 
and, therefore, different degrees of stiffness. Measurements were obtained using laser-
induced SAWs and ARF-based SAWs. The mean SWV value is shown as a vertical bar, and 
95% confidential interval is shown as an error bar.[115] 
P values of the t test between the two methods were 0.13, 0.79, and 0.19 for 6%, 9% and 
12% gelatin phantoms, respectively. There is no evidence to reject the null hypothesis that the 
mean values of the two measurement methods are equal. The statistical results shown in Fig6.5 
demonstrate that laser-induced SAW imaging has the ability of quantifying SAW velocities 
and thus is capable of quantifying shear modulus of materials such as biological soft tissues 
with accuracy on par with ARF-induced SAW imaging. 





Fig6.6 Displacement-time curves of SAWs at (a) 2.5 mm and (b) 3.3 mm away from 
laser/ARF excitation region. The excitation occurred at time zero. Spectrums of 
displacement time curves at (c) 2.5 mm and (d) 3.3 mm away from laser/ARF excitation 
region.[115] 
Fig6.6 shows the temporal behavior of SAW displacements induced by laser excitation 
or ARF excitation at two locations described in Section 6.2. The frequency spectrum of the 
displacement for both excitation sources at both positions were also plotted (Fig6.6 (c), (d)). 
Each displacement curve was averaged with five acquisitions using the same excitation and 
imaging parameters. At the first location which was 2.5 mm away from the excitation region, 




bandwidth being 1310 Hz. At the second location which was 3.3 mm away from the laser 
excitation region, the center frequency of the displacement dropped to 767 Hz with the 3 dB 
bandwidth being 1062 Hz. In comparison, with ARF excitation, the center frequency and 3 dB 
bandwidth at the first location were 452 and 790 Hz, respectively. At the second location, the 
center frequency and 3 dB bandwidth dropped to 410 and 655 Hz, respectively. The slight 
attenuation of center frequency and 3 dB bandwidth from the first location to the second 
location is due to the fact that as SAWs propagate further, the higher frequency components 
attenuate more than lower frequency components. The difference between the center 
frequency and 3 dB bandwidth of laser-induced SAWs and ARF-induced SAWs were observed. 
Generally, given that the laser excitation region (FWHM of laser excitation beam: 400 μm) is 
smaller than the ARF excitation region (FWHM of ARF excitation beam: 1.34 mm), laser-
induced SAWs can have a broader bandwidth than ARF-induced SAWs. This observation 
agrees with the theoretical relationships between the bandwidth and the spatial extent of the 
excitation[119]. Theoretically, the beam width for both the ARF-induced SAWs and laser-
induced SAWs are determined by wavelength of excitation source and numerical aperture of 
the transducer or the objective lens used for generation of SAWs. For the same numerical 
aperture, optical wavelength can be much shorter than ultrasound wavelength. Thus, laser-
based SAW imaging can provide a much smaller excitation beam. As a result, when SAW 




induced by laser excitation may provide better spatial resolution. 
Next, we presented the results of the third experiment where we compared the wave 
propagation when both the laser excitation and the ARF excitation were below the surface. 
The location of the photoabsorber embedded 3.3 mm below the phantom surface can be seen 
in the PA/US imaging result (Fig6.7 (a)). Displacement maps at three time points after the 
laser pulse or ARF pulse are presented in Fig6.7 (b) and (d). From the displacement maps 
obtained with the laser-induced SAWs imaging method, both SAWs and shear waves were 
successfully induced. 
 




the surface. (b) Laser-induced SAW and shear wave displacement maps in the phantom at 
three different time points. (c) Scatter plot of mean value of shear wave displacement 
amplitude, measured 0.78 ms after the laser pulse, as a function of optical fluence. The error 
bars show standard deviation (n=6). (d) ARF-induced SAW displacement maps in the 
phantom at three different time points.[115] 
Particularly, the SAWs and shear waves started to propagate separately at 1.5 ms after the 
excitation. This result demonstrates that in addition to superficial measurements of mechanical 
properties of materials, the applications of laser-induced SAW imaging can be potentially 
extended to measuring mechanical properties of materials at depth. Moreover, because of the 
straightforward relationship between shear wave velocities and the shear modulus of the 
measured material, shear wave velocities are generally more preferred than SAW velocities 
when deriving stiffness information of the material[120]. For ARF-induced SAW imaging, 
because the focus of the push beam had a small depth (2 mm below the surface), energy mainly 
remained in the surface region of the phantom, limiting the elastography analysis only to the 
surface layer. 
In the third experiment, we also investigated the relationship between the optical fluence 
and the amplitude of laser-induced shear waves. Three optical fluences ranging from 46 to 92 
mJ/cm2 were applied. The optical fluence and the corresponding amplitude of laser-induced 
shear wave were presented in Fig6.7 (c). Clearly, the optical fluence has a linear relationship 
with the amplitude of laser-induced shear waves (R2 = 0.93), suggesting that with higher 




it’s worth noticing that the energy applied here is below maximum permissible exposure for 
skin, which is 100 mJ/cm2 for 1064 nm wavelength based on the American National Standard 
Institute[48]. According to a previous study, two regimes can generate SAWs with laser 
excitation: ablative regime and thermoelastic regime. In the ablative regime, amplitudes of 
displacements have a quadratic relationship with optical fluence. In this scenario, 
displacements can reach several micrometers. In the thermoelastic regime, displacements are 
linearly dependent on energy and can only reach tens of nanometers, which is in agreement 
with our observations (Fig6.7 (b), (c)).  
6.4  Summary and discussion 
In this chapter, we conducted three experiments to investigate differences in laser-
induced SAWs and ARF-induced SAWs. In conclusion, we observed several differences in 
two generation mechanisms from each of the experiment. First, due to the difference in 
generation mechanism, the polarities of SAWs induced by laser excitation and ARF excitation 
are opposite. Second, the amplitudes of SAWs in two methods are different. Generally, the 
amplitude of ARF-induced SAWs is one to two orders of magnitude larger than the amplitude 
of laser-induced SAWs. The limitation of the amplitude of laser-induced SAWs is mainly due 
to the safety concern. When applying optical fluence higher than ANSI safety limitation, the 
laser excitation may cause ablation and thus may induce damage on the material. For 




friendly photoabsorber can be placed at the surface of the tissue to amplify SAW amplitude 
and simultaneously protect the underneath tissue from ablation[105]. Third, with laser excitation, 
it is feasible to induce perturbation within a much smaller region than with ARF excitation due 
to the difference in the size of the laser beam and the ARF beam. SAWs with higher bandwidth 
can thus be generated from laser excitation to potentially increase the spatial resolution of 
SAW velocity map. At last, when laser excitation region is located below the surface, both 
SAWs and shear waves can be generated, extending the application of laser-induced SAWs 
from the super facial regions to regions at depths. Besides, amplitude of laser-induced shear 




CHAPTER 7  CONCLUSION 
As an emerging technology, PAI has been proved to be a promising imaging modality. 
Previous clinical studies based on PAI have demonstrated the potential of PAI in multiple 
clinical applications, including cancer detection, arthritis evaluation, and vessels visualization. 
In this thesis, the representative research of PAI systems in clinical studies has been 
reviewed first. After then, the development of a 2D PA/US imaging system based on a high-
end handheld US imaging system is presented. The imaging capability of the system was 
verified by both of the phantom study and the in vivo study on the human forearm. Next, an 
optical fluence compensation method for handheld PA/US dual mode imaging is introduced. 
The efficiency of the proposed method was demonstrated through the phantom study and the 
in vivo study of a healthy breast.  
Next, PA/US imaging of thyroid nodules was performed with the self-developed 2D 
PA/US imaging system. In total, 10 thyroid nodules were imaged with PA/US imaging and 
CDFI. The comparison between the PAI and CDFI demonstrates that PAI is able to provide 
more abundant vascular information than CDFI.  
After then, the 2D PA/US imaging system was updated to the 3D functional PA/US 




generate laser pulse at wavelengths from 700 to 850 nm. For 3D imaging, a 3D scanning 
device was designed to move the linear transducer across the imaging region. Additionally, the 
updated PA/US imaging system was able to perform real time imaging. 
With the updated 3D functional PA/US imaging system, we carried out 3D functional 
PA/US imaging of breast tumors. A total of 24 cases including both benign breast tumors and 
malignant breast tumors were included in this clinical study. To perform the quantification 
analysis, we proposed an algorithm to analyze the volumetric mean SO2 in intra-tumor regions 
and in peri-tumor regions. The statistical results showed that the SO2 volumetric mean value 
of the malignant group was 7.7% lower than that of the benign group (P=0.016) and was 3.9% 
lower than that of the normal group (P=0.010). In peri-tumor regions, the SO2 volumetric mean 
value of the malignant group was 4.9% lower than that of the benign group (P=0.009). These 
results demonstrate that 3D functional PA/US dual mode imaging has the potential to 
differentiate benign breast tumors from malignant ones. With the aid of 3D functional PA/US 
imaging as a complementary imaging modality, the diagnosis efficiency of breast cancer can 
be potentially improved. 
At last, the author presented the study conducted in Georgia Institute of Technology. This 
study was motivated by the thought that in addition to PA signals, pulsed laser light may also 
induce shear waves or SAWs, the velocity of which can be used to infer stiffness information 




SAWs with ARF-induced SAWs, which is more commonly applied for measurements of tissue 
stiffness in previous studies. Our results demonstrate that the laser-induced SAWs imaging can 
be applied to measure tissue stiffness with the accuracy on par with ARF-induced SAWs 
imaging. Additionally, the bandwidth of laser-induced SAWs can be larger than that of ARF-
induced SAWs when laser beam size is much smaller than ARF beam size and as a result, 
laser-induced SAWs imaging has the potential to provide higher spatial resolution. At last, 
with the laser excitation located underneath the surface, both SAWs and shear waves can be 
generated, extending applications of laser-induced SAWs imaging from superficial regions to 
regions in depths. 
7.1  The major novelties of this thesis 
In this thesis, the author has presented a series of studies on handheld PA/US dual mode 
imaging in terms of system development, algorithm design, and clinical applications. The 
major novelties of this these are summarized as follows: 
1. The 2D handheld PA/US imaging system and the 3D functional PA/US imaging 
system developed in this study can be applied to perform PA/US imaging in clinical 
studies. Specifically, the 3D functional PA/US imaging system offers a solution to 
perform quantified 3D PA/US imaging. 




imaging is introduced. The efficiency of the proposed method was verified with both 
the phantom study and the in vivo study. The results demonstrate that the proposed 
method could aid in regaining PA signals from deeper regions (2~3 cm). 
3. 2D PA/US imaging of thyroid cancers was performed for the first time. The 
comparison between PAI and CDFI suggests that PAI could provide more abundant 
vasculature information than CDFI. As a result, PAI may have a great potential in 
diagnosis of thyroid cancers.  
4. To perform 3D functional PA/US imaging, we proposed to scan the linear transducer 
across the imaged tissue and applied this method to the clinical study for the first time. 
For quantification analysis of 3D functional PA/US imaging results, algorithms were 
designed for segmentation of intra-tumor regions and peri-tumor regions and for 
calculation of volumetric mean SO2 values of two regions. The statistical results 
demonstrate that 3D functional PA/US imaging has the great potential in 
differentiating benign tumors from early breast cancers.  
5. The comparison between ARF-induced SAWs and laser-induced SAWs was 
performed for the first time. Specifically, the difference of bandwidths between ARF-
induced SAWs and laser-induced SAWs was first investigated. Besides, generation of 





7.2  The future of PA/US dual mode imaging in clinical applications 
As a promising imaging technology, PA/US dual mode imaging has shown great 
potentials in diagnosis of diseases including cancers and arthritis. However, there are still 
several challenges to overcome before PA/US dual mode imaging can be applied widely in 
clinical environments. First of all, although physicians are very familiar with the operation of 
PA/US imaging based on handheld US imaging systems, the traditional US imaging transducer 
has a limited reception angle, and thus has a limited capability in acquiring PA signals from 
multiple angles. This limitation can be addressed by designing transducers with larger 
reception angles in the future. Second, when performing functional PA/US imaging, the 
knowledge of local fluence is essential for calculating concentrations of absorptive 
components inside tissues. However, the accurate calculation of local fluence depends highly 
on the knowledge of the optical properties of imaged tissues, which can vary a lot in different 
types of tissues. Although several methods have been proposed for extracting functional 
information such as SO2 without knowing the optical properties of imaged tissues
[121], they 
still need to be further verified in clinical studies. Furthermore, large-scale clinical studies 
based on PAI need to be carried out in more potential applications, such as detecting ovarian 
cancer and arthritis, which have shown promising results in preclinical studies. At last, the 




Without significant improvement from traditional modalities, it would be hard for hospitals or 
physicians to spend both of the time and financial resources on advancement of this technology. 
However, with the above aspects addressed, the author believes that PAI will become an 
indispensable imaging modality in the future just like other mature imaging modalities such 












ERα PR HER-2 ki-67 p53 EGFR BI-RADS
SO2 inside 
tumours
SO2 in tumour 
surrounding 
regions
SO2 in opposite 
healthy breasts
1 34 L 0.6 fibromas ~2 ~ ~ ~ ~ ~ ~ 4a-4b 0.68 0.67 0.75
2 28 R 0.9 invasive breast cancer(carcinoma) G2 90% 70% 1+ 10% + 0 4 0.68 0.72 0.68
3 48 L 1 invasive breast cancer(carcinoma) G1 90% 90% 0 5% - - 4c 0.70 0.70 0.75
4 45 R 1 invasive breast cancer(carcinoma) G1 80% 90% 1+ 10% + - 4b-4c 0.75 0.75 0.72
5 31 L 1.1 fibromas ~ ~ ~ ~ ~ ~ ~ 3-4a 0.81 0.74 0.72
6 37 R 1.1 fibromas ~ ~ ~ ~ ~ ~ ~ 4a 0.83 0.78 0.75
7 52 L 1.2 invasive breast cancer(carcinoma) G1 85% 80% 2+ 15% - - 4b-4c 0.66 0.66 ~
8 32 L 1.2 breast adenosis ~ ~ ~ ~ ~ ~ ~ 3-4a 0.74 0.78 0.73
9 53 R 1.2 breast adenosis ~ ~ ~ ~ ~ ~ ~ 4a 0.80 0.81 0.81
10 66 R 1.3 invasive breast cancer(carcinoma) G2 90% 60% 0 10% + - 4c 0.62 0.75 0.81
11 31 R 1.5 fibromas ~ ~ ~ ~ ~ ~ ~ 4a 0.84 0.80 0.79
12 58 R 1.5 invasive breast cancer(carcinoma) G3 - - 3+ 30% + - 4c 0.70 0.69 0.74
13 44 L 1.6 invasive breast cancer(carcinoma) G1 80% 90% 2+ 5% - - 5 0.72 0.75 0.79
14 67 L 1.7 invasive breast cancer(carcinoma) G3 90% 90% 0 12% + 0 4c 0.74 0.77 0.76
15 50 R 1.7 invasive breast cancer(carcinoma) G2 70% 80% 3+ 60% + - 4c 0.75 0.73 0.73
16 49 L 1.7 invasive breast cancer(carcinoma) G3 + + 1+ 20% - ~ 4b-4c 0.76 0.72 0.73
17 50 R 1.7 invasive breast cancer(carcinoma) G2 95% 95% 0 5% - 0 4b-4c 0.71 0.76 0.74
18 48 R 1.8 invasive breast cancer(carcinoma) G2 80% 80% 1+ 2% + ~ 4c 0.66 0.66 0.69
19 25 L 1.8 fibromas ~ ~ ~ ~ ~ ~ ~ 3-4a 0.79 0.79 0.74
20 39 R 2 invasive breast cancer(carcinoma) G2 85% 55% 2+ 10% - + 5 0.68 0.73 ~
21 30 L 2 fibromas ~ ~ ~ ~ ~ ~ ~ 4b 0.71 0.78 0.77
22 34 L 2 invasive breast cancer(carcinoma) G3 - - 2+ 75% - + 4c 0.69 0.75 0.69
23 55 L 2 invasive breast cancer(carcinoma) G2 90% - 1+ 5% + - 5 0.71 0.70 0.77
24 47 L 2 invasive breast cancer(carcinoma) G2 - - 1+ 60% + + 5 0.77 0.77 0.74
1: right/left
2: no data available
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